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Abstract
Morbidity and mortality attributable to asthma arise mainly from contraction of
airway smooth muscle (ASM) and resulting bronchospasm. Bronchospasm that is
induced in the laboratory is easily reversed by a spontaneous deep inspiration (DI)
whereas bronchospasm that occurs spontaneously in asthma is not. In response to a
spontaneous DI, contracted ASM fluidizes rapidly and then resolidifies slowly, but
molecular mechanisms accounting for these salutary bronchodilatory responses –and
their dramatic breakdown in asthma– are unknown. Using a multi-scale approach, I show
here that both the baseline contractile force and the fluidization response of ASM are
independent of the cytoskeletal protein zyxin, whereas the resolidification response is
zyxin-dependent. At the levels of the stress fiber, the isolated cell, and the integrated
airway, zyxin acts to stabilize the contractile apparatus and promote the resolidification
response. More than just the motor of contraction, ASM is thus viewed in the broader
context of a self-healing active material wherein resolidification and its molecular
determinants contribute to the biology of bronchospasm.
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…when the breathing is inclined to be asthmatical…the spasm
may be broken through, and the respiration for the time ren-
dered perfectly free and easy, by taking a long, deep full, inspi-
ration. In severe asthmatic breathing this cannot be done.
Henry Hyde Salter
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Introduction
1.1 Bronchospasm, Deep Inspiration, and theRole of Zyxin
Of all known bronchodilators, the most eﬀective are the deep inspirations (DIs) that
occur spontaneously in humans roughly once every 6 minutes [1–3]. This salutary
bronchodilating eﬀect of a DI has been attributed to the manner in which stretch
fluidizes the airway smooth muscle (ASM) cell and thereby ablates contractile force
[4, 5]. In the face of appreciable ASM activation, airway patency in vivo is very much
dependent upon the act of breathing itself and is therefore sustained dynamically, not
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statically [4, 6–8]. Simply put, breathing is good for breathing [9].
During an asthmatic attack, however, this virtuous positive feedback can collapse
[8, 10–12]. This collapse in asthma has been associated with increased contractile
stimulus of airway smooth muscle (ASM), increased ASM mass, and decreased lung
parenchymal tethering forces attributable to increased airway wall thickness and
decreased lung recoil [8, 13–16]. Acting alone or in concert, each of these factors tends
to cause ASM to stretch less with each DI [4, 8, 12, 17], fluidize less, and thus allow the
ASM to become stiﬀer still. Eventually a tipping point is reached beyond which ASM can
become so stiﬀ that it cannot be stretched by parenchymal tethering forces and thus
becomes virtually frozen in the so-called latch state [4, 18–21]. ASM would thereafter
remain refractory to the salutary eﬀects of a DI, and stuck in a shortened and stiﬀened
static state until the contractile stimulus is removed or bronchodilator drugs take eﬀect.
Accordingly, this physical picture suggests dynamic equilibration driven by positive
mechanical feedbacks on the one hand versus collapse to a static frozen state on the other
(Figure 1.1). As such, it provides a plausible explanation of why a DI can be so eﬀective
in the normal lung but not in the asthmatic lung [22, 23]. Molecular mechanisms
responsible for this stark diﬀerence remain less clear, however.
Relaxation of activated ASM in response to stretch is marked by disruption of
actin-myosin interactions [21, 24] and other weak bonds together with rapid fluidization
of the cytoskeleton through loss of actin stress fibers (SFs), with resulting reduction of
cellular contractility and stiﬀness [5, 25]. The prompt fluidization response is followed
by a slow and ATP-dependent resolidification response wherein cellular contractility,
stiﬀness and structure return slowly to baseline levels [5, 25, 26]. Whereas fluidization
2
Figure 1.1: Schematic of the positive feedback loop of bronchospasm in the asthmatic airway.
Increasingly solidiﬁed cytoskeleton in ASM cells promotes a more solid-like ASM. This more solid-like
ASM is stiﬀ enough to inhibit stretch-induced ﬂuidization from a deep inspiration, which is necessary
to reverse the solidiﬁcation of the cytoskeleton. When ﬂuidization is able to overcome a softer ASM, it
promotes bronchodilation. Adapted from Krishnan et al, 2008 [23].
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occurs on the timescale of seconds or less, resolidification occurs in an ATP-dependent
manner on the timescale of minutes or more [5, 25]. Slow and ATP-dependent
resolidification necessarily comprises reorganization, repolymerization and adaptation of
focal adhesions, the cytoskeleton (CSK) and the contractile apparatus [5, 26–29], and
thus implies active reassembly. Molecular determinants of that reassembly and its rate of
progression could become interesting therapeutic targets because, were resolidification
to be blocked, ASM would be unable to reassemble and contract. However, specific
determinants of that reassembly remain to be identified.
I focus here on the LIM protein zyxin, a highly dynamic and mechano-responsive
regulator of the actin cytoskeleton. In murine embryonic fibroblasts (MEFs) during
isometric conditions, zyxin localizes predominantly to focal adhesions [30, 31]. After
periodic cyclic stretches are imposed, however, zyxin localizes predominantly along actin
stress fibers (SFs), which stabilize and thicken [31] as zyxin together with VASP and
α-actinin are recruited to sites of highest SF strain [32]. Although the zyxin =  mouse
exhibits no known phenotype [33], I noted with interest that zyxin-mediated SF repair
occurs on a timescale comparable to that of resolidification of ASM after stretch [5, 32].
Accordingly, here I used cells and tissues from wild type and zyxin =  mice in a
multi-scale approach to test the hypothesis that resolidification of ASM after stretch is
dependent upon zyxin. During static isometric conditions I found that zyxin plays little
or no role in determining ASM cell stiﬀness or net cell contractile force. However, during
the resolidification following stretch-induced fluidization, zyxin impacts the dynamics of
contractile force recovery.
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1.2 A Multi-Scale, Interdisciplinary Approach to a Complex
Problem
In order to explore the role of zyxin in airway smooth muscle, I developed a multi-scale,
interdisciplinary approach, collecting data at the level of the actin stress fiber, the isolated
ASM cell and the integrated airway ex vivo. This approach combined quantitative
measurements of cell material properties and cell-exerted forces with physiological
studies of the integrated airway from both wild type and zyxin =  mice. Because
bronchospasm is a complicated and multi-level emergent phenomenon, this systems
approach allowed me to integrate my findings from molecule to tissue and allowed for
greater insight than a traditional reductionist approach.
Executing this multi-scale project required the development of new methods, the
adaptation of previous methods to focus on airway mechanics, and the partnership of
expert collaborators. The work on imaging protein dynamics was made possible through
a collaboration I established with Mark Smith in the Beckerle lab at the Huntsman
Cancer Institute, and the work on precision cut lung slices (PCLS) was greatly advanced
by collaborations I developed with the lab of Julian Solway at University of Chicago and
the lab of Alan Fine at Boston University Medical School. The successful execution of
both protein dynamics and PCLS experiments would not have been possible without the
assistance of Ramaswamy Krishnan at the Center for Vascular Biology Research at Beth
Israel.
To scale observations of ASM from molecule to cell to tissue required the use of a wide
range of methods spanning cell biology, biophysics, and lung physiology. To measure
protein dynamics immediately following transient stretch of physiologic magnitudes,
5
working with my collaborators Mark Smith and Rama Krishnan, we adapted the cell
stretch system of Krishnan et al. [25] to work with high-resolution protein imaging on a
spinning disk confocal microscope. This enabled us to observe for the first time zyxin
localization as early as 5 seconds following a transient stretch. To measure nanoscale
rearrangements of the cytoskeleton and cell cortical stiﬀness, I tracked nano-scale
motions of beads adhered to the cytoskeleton and used optical magnetic twisting
cytometry (OMTC) [34, 35]. This allowed me to see the contribution of zyxin to static
cell mechanics at both subcellular and cellular levels. To measure static isometric and
dynamic strain-responsive cell traction forces, I used Fourier Transform Traction
Microscopy (FTTC) [25, 36]. This revealed the role of zyxin in modulating cell-exerted
traction forces under both static isometric conditions and with dynamic strain. To
measure airway responses to contractile agonists and physiologic stretch ex vivo, I
measured contraction and dilation of airways in PCLS in response to contractile agonist
stimuli and isotropic strain [8, 37, 38]. In order to bring these PCLS to our lab, I
developed a method to cryopreserve PCLS for stable storage and transport [39]. These
methodologies brought to light how our cell and molecular level observations translated
to the integrated airway. Combining all of these findings gave a clearer picture of the
dynamic role of zyxin in airway mechanics.
1.3 Organization of thisWork
This work describes the role of zyxin in airway dynamics scaling from the level of
molecular rearrangement to the integrated airway ex vivo. Chapters 2 and 3 comprise key
background information relevant to the novel work presented in the thesis. Chapter 2
consists of a review of the literature on deep inspiration, airway smooth muscle, and
zyxin, with a special focus on the innate heterogeneity in cell mechanical properties.
6
Chapter 3 provides an in depth overview of the methodology used in this thesis, and
describes both how various tools and techniques work as well as why they were chosen
for this particular work. Chapter 4 describes the discovery of a novel method to
cryopreserve murine PCLS, which I developed in order to complete the integrated airway
studies. Chapter 5 focuses on the role of zyxin at the subcellular and cellular level; zyxin’s
contribution to static isometric cell mechanics and zyxin’s role in cellular responses to
stretch. Chapter 6 focuses on the role of zyxin at the tissue level; how zyxin influences
integrated airway responses to stimulation with contractile agonist and to physiologic
stretch. Lastly, Chapter 7 summarizes these findings and draws conclusions on the role of
zyxin in bronchospasm, as well as suggesting questions to explore in future studies.
7
2
Literature Review
Here I provide a concise overview of previous work on airway smooth muscle (ASM),
deep inspiration, and the role of zyxin in cytoskeletal mechanics. Work in these fields
constitutes the foundation of the ideas presented in this thesis. In this review I discovered
an interesting gap of understanding separating this literature on cell mechanics compared
with the emerging field of single cell biology. In the later part of this chapter I elaborate
that gap and propose a hypothesis to unify existing observations.
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2.1 Deep Inspiration andAirway SmoothMuscle
2.1.1 Asthma morbidity and mortality is a substantial problem for
global health
Asthma is one of the world’s most common chronic diseases, aﬀecting an estimated 300
million people worldwide, predominantly in middle and high income countries [40].
Still, asthma deaths, estimated in 2009 at 250,000 worldwide, occur predominantly (over
80%) in low and lower-middle income countries [41]. However, this relatively low
fatality rate minimizes the overall impact of asthma: the World Health Organization
estimates that 15 million disability-adjusted life years (DALYs) are lost every year due to
asthma, representing 1% of the total global disease burden (Figure 2.1)[41]. In the
United States alone, 8.2% of adults and 9.5% of children are currently diagnosed with
asthma. This disease burden results in 14.2 million physician oﬃce and 1.8 million
emergency room visits every year [42]. Each year, about 1 in 2 people (about 12 million)
diagnosed with asthma experience an asthma attack, suggesting that their current
treatment is insuﬃcient [42]. Additionally, asthma has a serious economic impact,
costing the United States about $56 billion a year in medical costs and lost school and
work days [42]. Although there are many treatments available to manage the symptoms
of asthma, to date there is no cure. Worse yet, two of the most prescribed treatments for
symptom management, β2 adrenergic receptor (β2AR) agonists and corticosteroids, do
not work for all asthma patients. Despite extensive use of β2AR agonists, approximately
10% of asthma patients are unable to control their disease and exhibit severe symptoms
[43]. Similarly concerning is the observation that even mild asthmatics who are treated
long-term with β2AR agonists frequently develop a tolerance to its eﬀects [44, 45]. This
can lead to a reduced response to β2AR agonists treatment during emergent
9
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Top 30 Leading Causes of DALYs Lost Worldwide
Figure 2.1: Asthma is the 25th leading cause of DALYs lost annually worldwide. Asthma is one of
the most common chronic diseases in the world and has a comparable public health impact to diseases
such as diabetes and cirrhosis of the liver [40]. Asthma DALYs lost are shown in red, other chronic non-
infectious diseases are shown in green, and all other causes are in blue.
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bronchospasm events [45]. This stems from changes in the β2AR including short-term
phosphorylation and coupling with the Gi subunit, and long-term decreases in
expression, which ultimitately lead to β2AR desensitization [46]. Further, 5-10% of
asthma patients are refractory to corticosteroid treatment, another common treatment
[47, 48]. These problems with current asthma treatments underscore the need to
continue to develop new therapies for asthma. It is our hope that with a greater
understanding of the physiological mechanisms that give rise to asthma, the tremendous
burden of this disease can be reduced.
2.1.2 A brief history of deep inspirations
It was more than 150 years ago that Henry Hyde Salter [10] first noted that a
spontaneous DI could reverse bronchospasm totally in mild asthma but not in severe
asthma. But it took nearly a century until Nadel and Tierney [1] picked up that thread
and showed that DIs temporarily reverse the increase in airway resistance induced by
bronchospasm. Not long after, Bendixen et al. [2] suggested that DIs comprise an
integral part of airway homeostasis and showed that DIs occur spontaneously in humans
at a regular intervals –approximately once every 6 minutes–which is now seen to
coincide roughly with the interval required for ASM resolidification (Figure 2.2). In
controlled studies matched for the severity of airway obstruction across groups, Lim et al.
[11] demonstrated that a DI reverses the obstruction that is induced in the laboratory,
but not the obstruction that occurs in the spontaneous asthmatic attack, and even tends
to exacerbate that spontaneous obstruction. These important observations
notwithstanding, response to a DI was considered for the most part to be an
epiphenomenon until Skloot et al. [12] demonstrated convincingly the central role of the
DI in maintenance of airway patency –and the failure of the DI to reverse bronchospasm
11
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Figure 2.2: Deep inspiration frequency is the same timescale as resolidiﬁcation of ASM. A experi-
ment from this thesis showing normalized changes in net contractile moment in wild type murine primary
ASM cells following a series of three stretches mimicking DIs at 0, 310 and 620 seconds.
in asthma– whereupon the phenomenon came to be widely appreciated as being a causal
factor in asthmatic obstruction [49]. While certain evidence suggests otherwise
[17, 50, 51], the preponderance of evidence now points to nonlinear positive mechanical
feedbacks between the ASM and the dynamic mechanical load against which that ASM is
contracting [4, 8, 24, 52]. Moreover, the isolated intact airway smooth muscle strip
contracting against a dynamic physiological load expresses these very same dynamic
behaviors, thus ruling out systemic mechanisms of neural or humoral origin [8, 21].
2.1.3 Airway smoothmuscle as motor or material? Disordered, glassy,
adaptable
All smooth muscles are defined by the absence of the ordered structure that is
characteristic of striated muscle [53]. Nonetheless, for a long time smooth muscle was
thought to operate functionally by some similar but hidden sliding filament mechanism,
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with the main functional diﬀerence being merely that the unloaded shortening velocity in
smooth muscle is far slower [54, 55]. The reason for this diﬀerence remained the central
unanswered question in the field until Dillon and Murphy finally showed that unloaded
shortening velocity in smooth muscle is time-dependent [56]. Unlike the control of
acto-myosin cycling by the stearic switch-like action of tropomyosin in striated muscle,
that cycling and its time dependence in smooth muscle was seen to be a regulated process
under the action of phosphorylation of the 20 kDa myosin regulatory light chain.
Murphy and colleagues then postulated the existence of a dephosphorylated but bound
slowly cycling myosin bridge, which they termed the “latch bridge”, and showed that
latch could explain all data that was then available [56, 57]. But even with the new
unifying concept of latch, all myosin II motors in smooth and striated muscle alike were
imagined nonetheless to operate within the strict framework of stable sliding filaments
[58–60], with its associated classical notions of optimal filament overlap, optimal muscle
length, and optimal muscle force. To great surprise, these classical notions borrowed
from striated muscle for application to smooth muscle were subsequently shown to be
totally inapplicable. With the discovery of smooth muscle adaption [61] it became
quickly appreciated that adhesions, cytoskeleton and contractile apparatus of ASM are
highly dynamic, plastic, and adaptable structures characterized by high rates of turnover
and remodeling. Such remodeling enables smooth muscle to adapt its microstructural
configuration so as to produce virtually the same active force over a huge range of muscle
lengths (Figure 2.3) [61]. If sliding thick and thin filaments exist at all in smooth muscle,
the implication is that they must be evanescent [63]. Borrowing ideas from the physics of
soft condensed matter, definitive biophysical studies subsequently showed that smooth
muscle adaptation, when considered at a coarse-grained level, conforms closely to the
notion of a glassy material perched close to a glass transition [5, 26, 35]. That is to say,
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Figure 2.3: Force-length curves measured in the same muscle before and after adaptation. Length
adaptation (black arrows) shifts the curve, which boosts the active force at shorter muscle lengths (grey
arrow). This substantial eﬀect is believed to be important in ASM hyperresponsiveness. The ASM can
adapt to produce the same force over a broad range of muscle lengths. Accordingly, ASM has no optimal
force or length. Adapted from Wang et al., 2001 [62].
smooth muscle structures, upon activation or imposed mechanical stretch, undergo a
transition between fluid-like and solid-like glassy material states, with fluid-like states
corresponding to the greatest rates of remodeling and adaptation, and solid-like states
being far stiﬀer and corresponding to comparatively smaller rates of remodeling. In the
transition from fluid-like to solid-like states following a transient stretch of physiological
magnitude, moreover, ASM resolidification was shown to be dependent upon ATP [5],
thus indicating the presence of active molecular processes but of non-specified kinds [5].
2.1.4 Understandingtheregulationofactincytoskeletaldynamics in
the contractile cell
Much work has been done to understand myosin cross-bridge cycling and myosin
ATPase activity in contractile cells [54–56]. The movement of myosin heads along actin
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filaments to produce tension in a shortening cell has been well described [64]. However,
smooth muscle contraction additionally requires the polymerization of actin [65–67].
Actin, the most abundantly expressed protein in the cell, forms filaments made up of
double-stranded helical arrays of actin monomers, which are constantly being exchanged
with the pool of soluble monomers in the cytosol. These actin filaments are anchored to
the extracellular matrix by mechano-sensitive adhesion complexes [68, 69]. It has long
been known that the inhibition of actin depolymerization suppresses tension generation
in the contractile cell [65]. It has also been shown that contraction of the smooth muscle
cell decreases the ratio of g-actin (soluble) to f-actin (filamentous), shifting more actin
from the cytosol into actin filaments [67, 70]. Interestingly, while it does suppress
tension generation, the inhibition of actin polymerization with cytochalasin D does not
aﬀect intracellular Ca2+, myosin light chain phosphorylation, or myosin ATPase activity
in the smooth muscle cell [66]. Additionally, the inhibition of N-WASp-induced actin
polymerization inhibits tension without eﬀecting myosin light chain phosphorylation
[70]. However, the inhibition of myosin light chain kinase does not aﬀect
agonist-induced actin polymerization in smooth muscle [71]. Taken together, these
studies suggest that the regulation of actin filaments exists in a parallel pathway to the
conventional activation of smooth muscle contraction via myosin ATPase activity. Much
work remains to be done to clarify the complex and dynamic regulation of actin filaments
and the contractile scaﬀold. However, it appears clear that characterizing actin regulation
in smooth muscle is essential our understanding of smooth muscle contraction, both in
normal physiology and in disease states, including bronchospasm.
15
2.1.5 Zyxin in cell adaptation, resolidification and self-healing
Crawford and Beckerle [30] first characterized zyxin and later identified LIM and
α-actinin binding sites as well as α-actinin, CRP and members of the Ena/VASP family as
binding partners [72–75]. Zyxin is an 82 kDa protein that is found in cell-cell and
cell-ECM adhesions, shows Arp2/3-independent actin-polymerization activity [76], and
plays a role in cell spreading and proliferation [77]. When cells are mechanically stressed,
zyxin mobilizes from focal adhesions to actin stress fibers [31], and contributes to
strain-dependent remodeling of the actin cytoskeleton and force-dependent changes in
zyxin binding aﬃnities [31, 78], although the directionality of these shifts remains a
matter of some dispute [79, 80]. Zyxin =  cells have also been shown to have faster
migration, increased adhesion to ECM proteins, and deficits in actin remodeling [81].
More recently, zyxin has been shown to be a key player in the repair and maintenance of
actin stress fibers (SFs) [32, 82]. It was observed that actin SFs experience periodic strain
events, where traction forces transiently increase followed by thinning of co-localized
SFs, and lower traction forces [32]. Zyxin is preferentially recruited to these
aforementioned sites of SF strain, where it facilitates the recruitment of α-actinin, an
F-actin crosslinking protein, and VASP, an actin barbed-end-binding protein (Figure
2.4)[31, 32, 72]. Interestingly, the recruitment of α-actinin and VASP is significantly
compromised in zyxin =  murine embryonic fibroblasts (MEFs), while zyxin
recruitment still occurs in the absence of α-actinin or VASP [31, 32]. By recruiting key
proteins that stabilize SFs, zyxin prevents SF ruptures; zyxin =  MEFs experience a
significantly higher rate of SF breaks [32]. However, despite these myriad diﬀerences
observed in zyxin =  cells, the zyxin =  mouse shows no apparent phenotype [33].
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Figure 2.4: Zyxin facilitates stress ﬁber repair by recruiting VASP and α-actinin. Actin SFs period-
ically experience strain events, where the actin ﬁlaments begin come apart, weakening the stress ﬁber.
When this occurs, zyxin is recruited to these sites, and brings along VASP, an actin barbed-end binding
protein. Subsequently, zyxin facilitates the recruitment of α-actinin, an actin cross-linking protein. These
proteins stabilize and repair the actin stress ﬁber. Adapted from Smith et al., 2010 ( [32].
2.2 SingleCell Biology andCellMechanics
As researchers in our lab and others began to piece together a better picture of cell
mechanics in ASM and other tissues, an interesting, and as yet unexplained phenomenon
was identified. Adherent cells of many types and under a variety of conditions were
found to have extremely heterogeneous mechanical phenotypes, even within clonal cell
populations [5, 25, 83–86]. These distributions of cell stiﬀness and contractility were
found to be log normal, which implies a fat tailed distribution with many more cells lying
far from the mean than would be expected in a normal distribution [25, 83–85]. In this
second part of the review, I will explore the possible causes of this phenomenon and
suggest a new approach to elucidate the relationships between biochemical signaling
events within the cell and emergent cell mechanical properties.
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2.2.1 Innate heterogeneities in cellmechanics
The study of single cell mechanics has come a long way over the past two decades. Where
once cell material properties were inferred from images of actin stress fibers and the
wrinkling of flexible substrates [87, 88], now they are quantified using methods such as
optical magnetic twisting cytometry (OMTC) and Fourier Transform Traction
Microscopy (FTTM) [36, 83, 89]. While these advances have yielded answers to a wide
range of questions, I focus here on the finding of large heterogeneities in cell mechanical
properties.
Heterogeneity in single cell mechanics was first discussed in the work of Fabry et al. in
2001, where he demonstrated a log normal distribution of cell stiﬀness in cultured
adherent human ASM cells [83]. Intriguingly, Fabry et al. showed that treatment with
contracting and relaxing agonists did not substantially change this log normal
distribution of cell stiﬀness [83]. Later work by Deng et al. confirmed the log normal
distribution of cell stiﬀness, and showed further that while measures of the elastic (G’)
and viscous (G’’) properties of individual cell varied according to a log normal
distribution, the loss tangent (G’/G’’) was far less variable, suggesting that variations in
cell stiﬀness are pegged to the maintenance of a set level of hysteresivity [84]. Balland et
al. subsequently confirmed the observation of log normal distribution and high
variability of cell stiﬀness using optical trapping [85]. The work of Wang et al. further
showed that measures of cell stiﬀness and contractility closely correlate with one another
[34]. Recent advances in measuring cell-exerted forces in a higher-throughput manner
have improved another tool in the field of single cell mechanics. In 2009, Krishnan et al
used FTTM to measure contractile force in adherent human ASM cells and confirmed
the same log normal distribution of net contractile moment in the isometric cell [25].
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Figure 2.5: Cell stiﬀness is log normally distributed. The distribution of isometric stiﬀness of primary
HASM cells (G*) is log normal for control, scrambled siRNA treatment, and zyxin siRNA knockdown. The
raw data are shown by the dashed lines, and are ﬁt by log normal curves shown by the solid lines.
Similarly, the work in this thesis shows log normal distributions of both cell stiﬀness and
net contractile moment in MEFs and human ASMs with and without zyxin (Figure 2.5).
From the above observations and others, it appears that the finding of log normal
heterogeneity in cell mechanical measures is quite robust.
But what does it mean? The log normal distribution of cell stiﬀness and net contractile
moment invites questions as to the physiologic significance of those cells in the long tail
of the distribution. There exist many physiological processes, most notably in the growth
and metastasis of neoplasms, driven by a distinct subset of cells rather than average cell
behaviors [90, 91]. Could this stiﬀer and more contractile sub-population similarly
promote disparate cell behaviors? What drives this wide range of cell stiﬀness and
contractility? Very little work has been done to address these questions. In 2013, one
group found that the stiﬀness of mesenchymal stem cells (MSC) correlated closely with
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their diﬀerentiation into osteoblasts, with the stiﬀest subset of MSCs diﬀerentiating later
than softer MSCs [92]. However, most studies examining a physiological role for cell
mechanics still focus on average cell behaviors, ignoring so-called “outliers” in the long
tail and failing to correlate individual cell mechanical measures with gene expression or
cell behavioral measures in those same cells.
2.2.2 Hypotheses abound as to the cause of cell mechanical hetero-
geneity
Many hypotheses exist that could explain some or all of this observed heterogeneity in
cell mechanics, although they have not been extensively explored. Underlying this
discussion of single cell mechanical heterogeneity is the assumption that this variability is
not an artifact of culture. While identical measurements cannot be made of cells in tissue,
some evidence suggests that here, too, there is substantial variability. For example,
Minshall et al. and others have shown that ASM contractile responsiveness in tissue is
extremely variable [39, 93], which is reminiscent of in vitro studies of ASM cells showing
log normal variability in contractile responses to histamine [83, 94]. Accordingly,
although this discussion is by no means exhaustive, I will discuss several potential driving
factors behind the observed heterogeneity of single cell mechanical measures.
First, and most well characterized, is the role of cell spread area and aspect ratio in
determining cell stiﬀness and contractile force. Many studies have shown clear
relationships between cell spread area, cell width, focal adhesion size, and cell tractions
[94–97]. However, the correlation between these geometric factors and cell traction
forces is not perfect; there are clearly other factors that contribute to this variability. This
is not surprising, as cell area, width and length are normally distributed, whereas cell
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traction force and cell stiﬀness are log normally distributed [83, 94]. Intriguingly,
increases in traction force in human ASM cell stimulated with histamine are distributed
log normally, however these force increases do not correlate with cell area or shape
parameters [94]. Most importantly, none of these observed correlations demonstrate
why this variability emerges, or whether cell area and traction force are both sequellae of
some as-yet unidentified biological diﬀerence within the cell population.
Together with these observations on cell size and shape, come other hypotheses
regarding the geometry and ordering of the cytoskeleton, which is known to be
extremely dynamic and constantly remodeling. It has been well characterized that cell
division causes substantial shifts in the magnitude and localization of cell traction forces
[98, 99], although cell stiﬀness and traction force show log normal heterogeneity in
serum-starved ASM cells which are not dividing [25, 83]. Similarly, migrating cells also
show temporal and spatial heterogeneity in traction force [86], although the causes of
this are still unclear. It was recently demonstrated that durotaxis, or migration towards
stiﬀer extracellular matrix, is guided by small-scale force fluctuations in individual focal
adhesions [100]. However, as with observations of cell size and traction force magnitude,
it is unclear what is the direct causative factor that drives the cell to exert more traction
force.
Another interesting hypothesis emerges from the field of single cell analysis. Several
studies over the past decade have shown that single cell gene expression is also very
heterogeneous [101–104], and in many cases gene expression varies according to a log
normal distribution [103–107]. Recent work has shown that this log normal gene
expression can be caused by the stochastic on-oﬀ switching of transcription, often
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referred to as “transcriptional bursts,” where random diﬀerences in the amount of time
that transcription is activated result in large diﬀerences in gene expression (Figure 2.6)
[101, 108–111]. Interestingly, some recent studies have found that in certain pathways,
the stochastic expression of an individual protein can actually generate a diversity of
phenotypes [105, 106, 111]. One such study done by Feinerman et al., found that
stochastic variation in the expression of CD8 co-receptor and soluble hematopoietic
phosphatase 1 led to a substantial range of activation within a clonal population of T cells
[106]. Another study by Chang et al. showed that the expression of Sca-1, a stem cell
marker, was log normally distributed in a clonal hematopoietic cell population and that
the relative expression of this marker actually impacted a cell’s likelihood of
diﬀerentiating into a myeloid or erythroid lineage [105]. In these cases, examining only
the mean expression of a gene in the cell population obscures the contribution of single
cell expression levels to a diversity of phenotypes. It is possible that in the case of cell
contractility, we could also learn by examining single cell gene expression. Many proteins
are potentially of interest including myosin, myosin light chain kinase, α-actinin, lamin,
filamin, actin binding and severing proteins such as cofilin and gelsolin [112, 113], and
proteins in the LIM family [114, 115]. While the expression of these proteins in single
cells has not yet been examined in connection with cell mechanics, the field of single cell
analysis has given rise to several tools that could aid in this exploration.
2.2.3 Novel tools have emerged from the field of single cell analysis
New tools for single cell gene expression analysis have been reviewed previously
[109, 116], but I will highlight some key techniques in mRNA and protein analysis. The
development of mRNA-Seq for use in single cells by Kurimoto el al. revealed the single
cell transcriptome [117]. RNA-Seq is a deep-sequencing technique where RNA
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Figure 2.6: Rapid on-oﬀ switching of transcription drives the stochastic expression of genes. The
gene promoter switches between on and oﬀ states with characteristic time scales τon and τoﬀ. While the
promoter is “on,” transcription usually occurs at a constant rate, Km. Protein translation occurs at a rate
Kp. mRNA and protein degradation are described by a Poisson process with rates of γm and γp. All of
these rates can potentially be shifted with gene activation. The “bursting” hypothesis proposes that the
stochastic activation of transcription is the key driver of the observed heterogeneity in gene expression.
Adapted from Molina et al., 2013 [111].
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fragments are first converted to cDNA and then adaptors are added to both ends of the
molecule. These short fragments are read using high-throughput sequencing techniques
and the resulting reads are aligned with the reference genome or transcriptome [118].
This technique has since been developed further, providing a more complete view of gene
expression in the single cell [118, 119]. Another method of single cell mRNA analysis is
single-cell PCR. This was first described in Zhang et al, where they demonstrated that
polymerase clones or “plones” could be amplified from the DNA of single cells with good
coverage and high accuracy [120]. This technique was further refined for single cell
mRNA analysis by Taniguchi et al., where they used a single-cell cDNA library
immobilized on beads to measure the expression of multiple genes in a single cell [121].
Another recently developed technique to quantify mRNA is RNA FISH (florescence in
situ hybridization), developed by Raj et al. to measure gene expression in fixed cells using
fluorophore moieties fused to oligonucleotide probes that hybridize with specific mRNA
targets [122]. This method can resolve gene expression down to individual mRNA
transcripts and could be a good tool to examine gene expression in parallel with cell
traction forces, as it measures endogenous protein and can be used to measure multiple
genes simultaneously through the use of diﬀerent fluorophores [109, 122].
In addition to measuring gene transcripts, one can also measure protein expression in
single cells. Individual proteins can be labeled with fluorescent molecules using either
transfected fluorescently tagged protein reporters or single-protein antibody labeling.
The primary advantage of using fluorescently tagged proteins is the ability to do real time
imaging, but this comes at the cost of being able to measure endogenously expressed
proteins. Conversely, labeling with antibodies allows for the measuring of endogenous
protein expression, but cannot be done in real time. Because of this, combinations of
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these techniques are often used to compensate for their individual weaknesses [109].
Additionally, new technologies are continually being developed for single cell analysis.
Recently, RNA-Seq has been further improved for increased sensitivity and accuracy as
well as allowing for full-length coverage of the genome [119]. Lee et al. recently
described a technique called fluorescent in situ RNA sequencing (FISSEQ), where stably
cross-linked cDNA amplicons are sequenced within a cell or tissue [123]. Therefore,
FISSEQ allows for parallel detection of many transcripts in situ instead of only a few
genes at a time, as with RNA FISH [123]. Using recently developed tools for detecting
single-cell mRNA transcripts, such as RNA-Seq and RNA FISH, as well as techniques for
single-cell protein detection, we could begin to find an answer for the question of what
drives single cell heterogeneity in cell mechanics.
2.2.4 Anovelapproachtostudythemolecularrootsofheterogeneity
in cellmechanics
Recent advances in the field of single cell analysis have shed light on the possibility that
key insights into how cells function are missed by focusing on population means and
overlooking the role of cells in the tails of the distribution. This idea can be immediately
applied to the field of cell mechanics, where we already have excellent tools to examine
the mechanical properties of single cells [25, 36, 89]. Using these tools and those from
the field of single cell gene expression analysis discussed above, we could begin to study
the genetic diversity that underlies the substantial heterogeneity we observe in cell
stiﬀness and contractility. By searching for patterns between cell mechanical properties
and gene expression in single cells, we may discover new insights as to the key drivers that
regulate cell contractility. New correlations emerging from this line of inquiry could be
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further studied to determine the causal nature of the relationship. It remains unclear to
what extent gene expression variability drives the variability in we observe in cell
mechanics and conversely, to what extent cell mechanical variability drives variability in
gene expression. Pursuing an investigation of these relationships at the single cell level
could help us to better understand the relationship between complex biochemical
processes within the cell and emergent cell mechanical properties.
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3
Methodology
While the previous chapter explored the scientific background supporting
the ideas developed in this thesis, this chapter turns to the unique methodology
employed to pursue the central question of the thesis: what is the role of zyxin in airway
dynamics? I will lay out the reasoning behind the multi-scale approach chosen to explore
this question, and also provide context for the methods used in this work.
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3.1 Introduction: WorkingAcross Scales in a Systems Approach
In developing this thesis, I saw the problem of bronchospasm as being driven by
phenomena that scaled from molecular events in individual cells to changes in the airway
and lung tissue. As such, I sought to study bronchospasm as an emergent phenomenon at
multiple scales, in the hope that such an approach would be synergistic and reveal more
insight than a study of bronchospasm at only one scale. At the subcellular level, I was
motivated to explore the molecular events that give rise to the “frozen” cytoskeleton
observed in asthmatic airway smooth muscle [23]. I sought to better understand the role
of cytoskeletal regulatory proteins, with a central focus on zyxin, in promoting a “frozen”
versus a fluidized cytoskeleton. At the cellular level, I was motivated to characterize how
these molecular events give rise to the cell mechanical phenotype, with a particular focus
on cell responses to physiologic stretch. In particular, I sought to identify molecular
drivers behind resolidification of the cytoskeleton following stretch-induced fluidization
[5, 25]. At the tissue level, I looked to expand these findings to the integrated airway ex
vivo. I was motivated to explore how the multicellular nature and specific geometry of the
integrated airway impacted cellular responses to stretch, especially in the regulation of
the actin contractile apparatus by zyxin. The consistencies and inconsistencies observed
across these levels revealed zyxin as a nuanced regulator of ASM contractility in the
dynamic environment of the lung.
3.2 SubcellularMeasurements
3.2.1 High-resolutionmicroscopy of protein dynamics
Working with collaborators in Dr. Mary Beckerle’s lab at the University of Utah,
especially Dr. Mark Smith, and with Dr. Rama Krishnan, at the Center for Vascular
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Biology Research, we developed a system to image zyxin and actin dynamics
immediately following stretch. This system allowed us to track zyxin, actin, and cellular
tractions simultaneously immediately following the application of mechanical stretch.
Using GFP-zyxin and LifeAct transient transfections of zyxin =  MEFs, we were able to
visualize real-time changes in zyxin localization and actin SFs. Imaging was performed on
an inverted Nikon Tie (Nikon Instruments) equipped with either a Nikon 20X Plan Apo
NA .75 dry, or a Nikon 40X Apo LWD NA 1.15 water immersion lens. This system also
utilized an Andor spinning disk confocal (Andor Technology) and an Andor Ixon 885
EMCCD camera. Automation and image capture utilized Andor IQ software running on
a Hewlett Packard workstation. Time-lapse image sequences were collected with
10-second time resolution of GFP-zyxin and LifeAct. We adapted this system to apply
mechanical stretches by designing a small annular punch indenter that fit on the
condenser and could be lowered to the surface of the gel. The final positioning and
application of stretch were guided by precise movement of the stage in Z with a Piezo
stage insert. The punch used was a small bore stainless steel cylinder with inner and outer
diameters of 100 and 150 μm, respectively. This allowe us to apply measured stretches
across a physiologically relevant range (2.5-20%). This method comprised the first
attempt to observe zyxin dynamics within a cell immediately following a transient
physiologic stretch.
3.2.2 Measurements of spontaneous bead motion to approximate cy-
toskeletal reorganization rate
To measure the dynamic reorganization of the cytoskeleton quantitatively, cells were first
plated on collagen I-coated 96-well plastic plates at a density of 20,000 cells per well to
form a confluent monolayer. After 24-72 hours to spread, the cells were serum-starved
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Figure 3.1: Spontaneous bead motions as a proxy for cytoskeletal remodeling rates. Spontaneous
motions of a representative bead on a cell approximate cytoskeletal remodeling rates and are far larger
than the measurement noise (Scale bar = 10 μm). Total MSD increases with time (inset). Adapted from
Bursac et al. [35].
for another 24 hours and treated with RGD-coated 5 μm iron microbeads. Next,
spontaneous bead motions were optically recorded on a light microscope. Because the
RGD-coated beads are attached to the actin cytoskeleton itself via focal adhesions, these
spontaneous bead motions correspond with the remodeling of the underlying actin
cytoskeleton [35]. The overall rate of remodeling can be quantified by the mean square
displacement (MSD) over changes in time (Figure 3.1). Beads attached to cells in which
the cytoskeleton is remodeling rapidly exhibit more motions, leading to higher MSD
values. Here we define MSD as
hr2(Δt)i = h(r(t+ Δt)  r(t))2i (3.1)
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where r(t) is the bead position at time t, Δt is the time lag, and brackets indicate an
average over many starting times t and over all beads. The MSD value hr2(Δt)i, can be
plotted on a log-log scale versus time lag. Over short time scales, the MSD value shows
subdiﬀusive behaviors, while over longer time scales superdiﬀusive behaviors dominate
[35]. This superdiﬀusive behavior can be fit to the power law D(Δt)=t0)β, with cells
exhibiting higher rates of remodeling fitting curves with a higher D* [35, 124]. This value
is then used to compare remodeling rates between diﬀerent cells and conditions. For a
more complete discussion of MSD and cytoskeletal remodeling, refer to Lenormand and
Fredberg, 2006 [124].
3.3 CellularMeasurements
3.3.1 Optical Magnetic Twisting Cytometry (OMTC) to measure cell
stiffness
Cells were plated and left for 24-72 hours, depending on cell type and condition, to
spread and form mature focal adhesions. The cells were then serum-starved for a further
24 hours. RGD-coated 5 μm iron microbeads were added and incubated for
approximately 20 minutes to allow the cells to form focal adhesions on the beads (Figure
3.2A)[34, 89]. Both zyxin =  MEFs and zyxin knockdown HASM cells bound the
RGD beads similarly to cells with zyxin, likely due to the fact that integrin expression is
not compromised in the zyxin =  cell [81]. The RGD-coated beads were magnetized
and subjected to torque from a 30G magnetic field across a range of frequencies to collect
measures of cellular stiﬀness and elasticity. As with all OMTC experiments, lateral bead
displacements were measured by optical tracking (Figure 3.2B) and used to calculate
stiﬀness (an inverse relationship exists between lateral bead displacement and stiﬀness).
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Figure 3.2: OMTC as a tool to measure cell stiﬀness. A) Cells plated in a 96-well are treated with
ferromagnetic beads, which are then magnetized in one direction (white arrows) and subjected to a per-
pendicular alternating magnetic ﬁeld (black arrows) to collect cell rheology measures. B) Image showing
optical bead tracking. Scale bar is 50 μm.
Two values were collected for each bead and each pulse of the magnetic field. The first,
G’, or the in-phase constant, is a measure of the storage modulus of the cell, and
represents the elastic portion. The second, G”, or the out-of-phase constant, is a measure
of the loss modulus of the cell, and represents the dissipative portion. In this study, I used
G’, or the elastic modulus, as the primary measure of cell stiﬀness. For a more detailed
explanation of the calculation of G’ and G”, the best resources are Fabry et al, 2003 and
Lenormand and Fredberg, 2006 [124, 125].
3.3.2 Usingtractionforcemicroscopytomeasure singlecellcontrac-
tility
In order to measure cell-exerted forces, cells were plated on collagen-coated
polyacrylamide gel substrates (Young’s modulus of 1.2-11 kPa) containing florescent
marker beads and allowed to adhere and stabilize over 24-96 hours, depending on the cell
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Figure 3.3: FTTC as a tool to measure cell contractility. A) MEF on polyacrylamide gel. The red ellipse
indicates the cell of interest. B) Image of 200 nm ﬂuorescent marker beads used to visualize gel displace-
ments. C) Measured displacements of a single MEF (in μm). D) Constrained tractions of a single MEF (in
Pa).
type (Figure 3.3A). Images of marker beads were taken for individual adherent cells,
before and after the application of trypsin to gain a reference image of the gel (Figure
3.3B). By comparing the image of the beads with the cell still adherent to the gel and the
reference image of the gel with no cell attached, the displacements of the beads could be
calculated and then converted into a vector map of cell-induced displacements of the gel
(Figure 3.3C). As described previously in Butler et al. [36], the traction field was then
calculated from this displacement vector map using Fourier Transform Traction
Cytometry (FTTC) (Figure 3.3D). This traction field was subsequently used to calculate
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the net contractile moment of the cell, a scalar measure of the cell’s contractility
(expressed in picojoules-pJ).
3.4 TissueMeasurements
3.4.1 Using Precision Cut Lung Slices (PCLS) to measure airway hyper-
responsiveness and responses to physiologic stretch
Many in vivo mouse models have been developed for the study of asthma; however, there
is still no model that can reflect the severe airway hyper-responsiveness (AHR) response
to challenge with contractile agonists seen in asthmatics [126, 127]. Here, instead of
taking such an in vivo approach to examine bronchospasm, I examine the integrated
airway ex vivo using a novel dynamic Precision Cut Lung Slice (PCLS) model system.
PCLS has emerged as a promising method for observing individual airway responses to
pharmacological or mechanical stimulation, and has been refined greatly by Michael
Sanderson, who assisted in our development of the technique [38, 128–133]. Dassow et
al. first demonstrated the feasibility of biaxial distension of PCLS [133]. However, their
system, while functional, is extremely complex, and so our lab, in collaboration with
Julian Solway at the University of Chicago, has developed a more straightforward
approach to the problem of imposing mechanical stretch on PCLS [8]. The use of this
system allows the observation and quantification of airway constriction and resolution in
real-time and the application of quantified mechanical stretch to the tissue [8, 39].
3.4.2 Stretchof the integrated airway inmurine PCLS
In order to stretch the lungs in a manner that mimics breathing, I used an approach
similar to that used to stretch adherent cells. A vertical stainless steel annular “indenter”
was attached to a micromanipulator and centered above the airway of interest. The
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indenter was perforated above its edge in order to allow the free flow of solution in the
tissue bath to the PCLS of interest. The indenter was then used to push a ring of
parenchyma into the gel substrate periodically, stretching the encircled lung tissue
uniformly over the underlying gel. In this approach, radial strain can be transmitted to
the airway through its attachments to the lung parenchyma, closely approximating the
mechanism through which force fluctuations are transmitted to the airway in vivo. A
LabView-based program was used to control the micromanipulator. During periods of no
imposed stretch, the indenter was positioned so as to touch the PCLS, but not displace
the tissue. During periods of imposed stretch, the indenter started from this position,
and then was pushed into and withdrawn from the PCLS/polyacrylamide gel in a
triangle wave pattern. The system was calibrated such that a 250 μm displacement
amplitude corresponded with a 10% stretch of the luminal diameter of the airway, which
likely correlates with the stretch imposed upon airways during a deep inspiration.
3.4.3 Selection of PCLS as amodel to study bronchospasm
Some might suggest that an in vivo model using ventilation of live mice would have been
a stronger test of the role of zyxin in bronchospasm. However, there are several reasons
why I chose to use a PCLS system to look at airway constriction. First, while there exist
many models for inducing AHR in mice, there is no one perfect mouse model for asthma
[126]. As such, choosing one amongst the many AHR models would invite speculation
as to the importance of the chosen AHR induction in determining the experimental
result. Second, in the live animal models, it is diﬃcult to sort out the relative contribution
of airway smooth muscle contraction from other possible changes that might occur in a
given model including ASM proliferation, inflammation and mucus secretion [126]. By
looking directly at airway responses to contractile agonists, much of the complication
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created by the many additional variables present in the whole animal models is removed.
Finally, the PCLS system allows far greater control over the airway being studied. I was
able to apply measured stretches of varying magnitude and frequency to a specific airway
far more precisely than possible in the living lung. I was also able to apply drugs directly
to the airway of interest rapidly and with very tightly controlled concentration [128]. For
these reasons, I believe that our dynamic PCLS system is superior in this case to an in
vivo model to test ASM contractile responses and the ASM response to stretch in the
living lung.
While the PCLS was an ideal model system to study integrated airway responses to
contractile agonist stimulation and stretch, executing the experiments was hampered by
the limited culture viability of the murine PCLS, which are best used within a few days
[38]. Accordingly, to facilitate the PCLS studies in this thesis, I developed a method to
cryopreserve the PCLS while maintaining cell viability and contractile agonist
responsiveness [39]. In the next chapter, I will describe in detail this cryopreservation
method.
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Cryopreservation of the PrecisionCut Lung Slice
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Jeﬀrey J. Fredberg , and Ramaswamy Krishnan. Airway contractility in the precision cut lung
slice following cryopreservation. Am J Respir Cell Mol Biol, May 2014 (published online
December 2013). Volume 50, Number 5. Oﬃcial Journal of the AmericanThoracic Society.
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An emerging tool in airway biology is the precision cut lung slice (PCLS).
Adoption of the PCLS as a model for assessing airway reactivity has been hampered,
however, by the limited time window within which tissues remain viable. Here I
demonstrate that the PCLS can be frozen, stored long-term, and then thawed for later
experimental use. Compared to the never-frozen murine PCLS, the frozen-thawed PCLS
shows metabolic activity that is decreased to an extent comparable to that observed in
other cryopreserved tissues but no diﬀerences in cell viability or in airway caliber
responses to the contractile agonist methacholine or the relaxing agonist chloroquine.
These results indicate that freezing and long-term storage is a feasible solution to the
problem of limited viability of the PCLS in culture.
4.1 Introduction
In preclinical models of airway reactivity, responses to constrictor or relaxant agonists are
typically assessed using the intubated and ventilated living animal, the isolated airway
smooth muscle (ASM) strip, or the isolated ASM cell. Assessment in the living animal
oﬀers the advantage of studying the airway in its native microenvironment [126], but
because responses of individual airways are innately and dramatically heterogeneous
[83, 93, 134, 135], inference of airway behavior is indirect, complex and often ambiguous
[136, 137], as well as being costly in terms of time and money. The ASM strip
[18, 20, 138] or ASM cell [5, 25, 83, 139] isolated from trachea or major bronchi
provides a direct and unambiguous assessment of muscle contractility, but results so
obtained may not be representative of responses of muscle from smaller airways.
Moreover, such preparations lack the mechanical and humoral microenvironment
provided by parenchymal tethering and other cellular components of the airway wall in
situ. Accordingly, these preparations of isolated tissues and cells comprise an important
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tool but are of equivocal physiological relevance [140].
An attractive new preparation for studying reactivity of the small airway is the precision
cut lung slice (PCLS) [8, 38, 130, 133, 141–146]. Using the PCLS, airway narrowing can
be assessed by direct microscopic observation of individual airways of any size. While
there is no alveolar air-liquid interface and lung recoil is therefore not faithfully
maintained, the muscle microenvironment roughly approximates in situ conditions
[130]. Additional practical advantages of the PCLS include ease of preparation,
widespread applicability to nearly every animal species including human [8, 147], and
suitability for high-resolution imaging [38, 144]. In the PCLS even responses to neural
stimulation [143, 145] and stretch [8, 133, 146] have been evaluated.
Use of the PCLS for assessment of airway responsiveness is presently limited by tissue
viability in culture, however, which is only 3-6 days from time of tissue harvest [38]. This
limitation imposes scheduling diﬃculties and severely constrains the number of slices
that can be studied per lung. In addition to these limitations, my thesis work required
that the PCLS be prepared from animals in the Beckerle lab at the Huntsman Cancer
Institute in Utah and then shipped to Boston for my experiments, further complicating
the use of PCLS in my study. To overcome these limitations, I describe here a new
approach to collect, preserve, and then study airway contractility in the PCLS. Using the
conventional cryopreservative DMSO [148, 149], I demonstrated that murine PCLS can
be frozen, stored, and thawed for study at a later time.
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Figure 4.1: Viability is preserved in frozen-thawed PCLS. LDH assay shows no signiﬁcant diﬀerence
between frozen-thawed and never-frozen groups in the percentage of dead to live cell (n=22 PCLS in
each group).
4.2 Results
After slow freezing in 10% DMSO and rapid thawing at 37°C, frozen-thawed PCLS were
not statistically diﬀerent from never-frozen PCLS in fractional cell death, integrity of the
epithelial and smooth muscle layers, or contractile responsiveness to methacholine.
4.2.1 Freezing-thawing does not increase cell death or compromise
tissue integrity
Ciliary beating in the airway epithelium was robust in the frozen-thawed PCLS (data not
shown) and qualitatively similar between the never-frozen and the frozen-thawed groups.
The LDH assay showed that cell death was slight ( 1%) and similar in both the
never-frozen and the frozen-thawed PCLS (Figure 4.1). The MTT assay showed that cell
enzymatic activity was reduced in the frozen-thawed group (Figure 4.2, p<0.05, unpaired
two-tailed t-test), but these changes fell well within the range previously reported for
other cryopreserved tissues [150–152]. Immunohistology of PCLS thin sections showed
the airway epithelium and smooth muscle layers to be similarly intact in both never
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Figure 4.2: Cell metabolic function reduced but within acceptable range in frozen-thawed PCLS.
MTT assay showed a signiﬁcant reduction in cell metabolic activity after freeze-thaw (*, p<0.05) but well
within the acceptable range previously reported for other tissues [150–152]. These data are reported as
mean and standard deviation of formazan absorbance at 540 nm (n=18 PCLS in each group).
frozen and frozen-thawed PCLS (Figure 4.3). Microscopic observation showed that lung
parenchyma, blood vessels and airways of both never-frozen and frozen-thawed PCLS
were structurally intact (Figure 4.4A,B). Associated cell death was minimal and
predominantly localized along the edges of the PCLS and in the airway epithelium,
although even there the vast majority of cells were alive (Figure 4.4A,B).
4.2.2 Freezing-thawingdoesnotaltercontractile response tometha-
choline
In response to methacholine (MCh, 10-⁷ to 10-⁴ M), airway contractile responses in both
the never-frozen and the frozen-thawed groups were highly variable. These responses
varied slightly with initial airway size, with smaller airways (<200 µm) being more
responsive (Figure 4.5C, D, Figure 4.6). Irrespective of initial airway size, however,
contractile responses were not statistically diﬀerent between the never-frozen and the
frozen-thawed groups (p=0.1-0.5; Figure 4.5A, B, C, D). For example, at 10-⁴ MCh,
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Figure 4.3: Airway epithelium and smooth muscle layers are similarly intact in never frozen and
frozen-thawed PCLS. Sections of never frozen and frozen-thawed PCLSs were immunostained for
CC10 expression in the lung epithelium and SMA expression by airway smooth muscle cells. Nuclei of
the cells on sections were counterstained by hemotoxylin (Sigma). Scale bar, 50 µm.
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Figure 4.4: Cell death in PCLS is minimal and predominantly localized to airway epithelium. (A)
Representative bright ﬁeld and ﬂorescence images of live-dead stained never-frozen or frozen-thawed
PCLS at 10X magniﬁcation (Scale bar = 200 µm). (B) Representative bright ﬁeld and ﬂuorescence images
of live-dead stained never-frozen or frozen-thawed PCLS at 20X magniﬁcation (Scale bar = 200 µm).
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Figure 4.5: Airway contractility is preserved in frozen-thawed PCLS. In the never-frozen group the
mean diameter was 151 µm and the range was 88-389 µm; in the frozen-thawed group the mean diame-
ter was 175 µm and the range was 77-415 µm. (A) Representative images of airway contraction to MCh
(10-7-10-4 M) and airway relaxation to ChQ (1mM) in never-frozen and frozen-thawed groups (Scale bar =
50 µm). (B) When pooled, airway contraction and relaxation in never-frozen (n = 57 airways) and frozen-
thawed (n=46 airways) PCLS were not statistically diﬀerent with MCh or ChQ (p=0.2-0.4). Plotted are
mean and SEM. (C, D) In both groups, individual airways contracted heterogeneously. To assess the role
of initial airway size, I grouped airways into two bins: smaller than 200 µm (C) and larger than 200 µm (D).
Within each airway size bin, never-frozen and frozen-thawed airways did not show signiﬁcant diﬀerences
in their responses to MCh and to ChQ (p=0.1-0.5).
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Figure 4.6: Airway contractility is weakly dependent on airway size. Change in luminal area versus
initial airway diameter for never-frozen (closed circles, n= 57 airways) and frozen-thawed (open circles,
n=46 airways).
airway luminal area contracted to a mean value of 64% ± 9% (SEM) of the baseline in the
never-frozen group (n=57 airways) compared with a mean value of 69% ± 5% of baseline
in the frozen-thawed group (n=46 airways; p=0.2). At a time resolution of one minute,
we observed no diﬀerences in the rate of contraction with MCh between never-frozen
and frozen-thawed airways (Figure 4.7). Additionally, there was no significant diﬀerence
in the values for EC50 between the never-frozen and frozen-thawed groups (Table 4.1, p
= 0.24).
Condition EC50 forMCh
Never Frozen 3.99 x 10-⁷ M
Frozen-Thawed 2.97 x 10-⁷ M
Table 4.1: EC50 values are not signiﬁcantly diﬀerent for MCh in never-frozen and frozen-thawed
PCLS.
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Figure 4.7: Dynamics of airway closure are similar in never frozen and frozen-thawed PCLS. Time
series of airway responses to methacholine and chloroquine at a resolution of one minute. Increasing
doses of methacholine were added at 5, 10, 15, and 20 minutes and 1 mM chloroquine was added at 25
minutes.
4.2.3 Freezing-thawing does not alter relaxant response to chloro-
quine
To airways that were pre-constricted with MCh, as described above, I administered the
relaxant agonist chloroquine (1 mM) [153]. Relaxation responses were not statistically
diﬀerent between never-frozen and frozen-thawed groups (p=0.21; Figure 4.5A-C, 4.8).
Airways relaxed to a mean of 90% ± 2% of the baseline in the never-frozen group (n=57
airways) and 94% ± 2% of the baseline in the frozen-thawed group (n=46 airways). We
also observed significant dilation in response to the relaxing agonist formoterol in
airways from frozen-thawed PCLS (Figure 4.9), which in pilot experiments was of a
similar magnitude as observed in never-frozen PCLS (data not shown).
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Figure 4.9: Frozen-thawed airways dilate in response to formoterol, a relaxing agonist. As expect,
the frozen-thawed airways contracted approximately 15% with 10-6 M MCh. The airways subsequently
dilated to approximately 95% of their original baseline area. This response is similar to that observed in
never frozen airways.
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4.3 Discussion
Here I demonstrate for the first time that it is possible to freeze and thaw the murine
PCLS while maintaining unaltered responses to contractile and relaxant agonists.
Although cellular metabolic activity was somewhat reduced, cell death, ciliary beating,
and airway narrowing were not appreciably aﬀected. It remains unclear, however, if this
methodology might be useful to preserve nerve fiber endings, mast cells, or other
receptor targets on airway smooth muscle. These findings are of practical importance
because the time window for measurement of airway responses in the never-frozen PCLS
is limited to a few days [38, 141] whereas the time window for measurement in the
frozen PCLS is demonstrated here to extend as long as two weeks.
4.3.1 Development of the cryopreservationmethod
Storage times substantially longer than two weeks are plausible, as cryopreservation
studies in other tissues typically find that the duration of storage does not appreciably
aﬀect viability [154–157], and in pilot studies I found no changes in airway contractility
after 3 months. In slices of other organs, a variety of cryopreservation techniques have
been used [148, 149, 158, 159], although airway contractile responses in the PCLS have
never before been studied after cryopreservation. I used the conventional
cryoprotectant, DMSO, and obtained satisfactory results using a high concentration. At
this concentration, DMSO readily infiltrates the cell membrane, remains water-soluble
even at low temperatures, and has low cytotoxicity [148]. I chose a slow freezing rate of
1°C/minute to prevent the formation of ice crystals inside cells. I chose a rapid thawing
rate because pilot experiments showed less ciliary beating and more cell death in PCLS
thawed more slowly. These measurements were limited to 37°C, however, and do not
preclude other conditions including lower thaw temperatures. Ultimately, our method
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resulted in an average of 1% cell death in both never frozen and frozen-thawed PCLS. The
cell metabolic activity was significantly reduced in the frozen-thawed PCLS but well
within the acceptable range previously reported for other tissues [150–152].
4.3.2 Innate heterogeneity of airway responsiveness
Innate biological variability of airway responsiveness across airways even within the same
animal is quite large and does not follow a normal distribution [93, 134, 145]. For
example, Minshall et al. showed at the level of human lung slices that airway responses
are remarkably heterogeneous even in the same lung donors [93]. Even at the level of the
underlying smooth muscle cell, cellular contractility and other cellular mechanical
properties are known to be innately heterogeneous and distributed non-normally with
geometric standard deviations of about 3 [83, 85, 125, 160]. No factor of airway
geometry can account for these non-Gaussian heterogeneities, which seem to be innate
to the contractile units themselves. Accordingly, for statistical analysis of airway
narrowing I used the Mann-Whitney-Wilcoxon rank-sum test.
I found large variation in airway contractile response to MCh even for airways from the
same animal, the same experimental condition, and the same initial size (Figure 4.5B, C,
D), consistent with earlier studies demonstrating innate biological heterogeneity of ASM
contractility in tracheal smooth muscle strips, isolated ASM cells and the human PCLS
[8, 83, 93, 129, 134, 135, 161, 162]. Smaller airways were systematically more responsive,
however (Figure 4.5C, D, Figure 4.6). The airway narrowing that I observed was
comparable in extent with other recently published literature in the C57BL/6 mouse
showing airway narrowing of approximately 40% with 10-⁴ M MCh, as compared to the
36% mean narrowing reported in our control at the same dose [163, 164].
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4.3.3 Contractile and relaxing agonists
To test the eﬀects of cryopreservation on airway responsiveness I used the contractile
cholinergic agonist, MCh, and the dilating bitter tastant agonist, chloroquine. I chose
chloroquine because it causes a substantially greater bronchodilation in murine airways
compared with β-agonists [153] and, as such, I reasoned that any diﬀerences in
bronchodilation caused by cryopreservation would be made more apparent.
4.3.4 A novel method of cryopreservation that could enable broader
use of the PCLS
Together, the data reported here establish the frozen-thawed PCLS as a useful
preparation for study of airway responsiveness. By freezing and storing the PCLS, timing
of experiments becomes uncoupled from that of harvesting, and utilization of precious
samples is maximized. It seems likely that similar results could be obtained using human
tissues or genetically engineered laboratory animals, but this remains to be tested
directly. Freezing and thawing thus makes feasible the notion of a PCLS bank and
enables expanded use of this emerging ex vivo preparation.
4.4 Materials andMethods
4.4.1 Animals
Lungs were obtained from seven 20-week-old C57/BL6 mice ( Jackson Laboratory, Bar
Harbor, ME). The Boston University Institutional Animal Care and Use Committee
approved all animal procedures.
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4.4.2 Preparation and culture of PCLS
Each PCLS was prepared as described previously [142]. Following tracheotomy, excised
mouse lungs were insuﬄated with 1% low-melting point agarose in HBSS, followed by
air. The insuﬄated lungs were then placed in cold HBSS (Corning Life Sciences, MA,
USA). After the agarose gelled, the left lower lobe was separated and then sectioned into
slices 250 µm thick using a tissue slicer (Precisionary Instruments VF-300). Lung slices
were incubated at 37°C in 1:1 DMEM/F-12 supplemented with penicillin, streptomycin,
kanamycin, and amphotericin B (Invitrogen, MA, USA). Culture medium was changed
once an hour for the first 4 hours and once a day thereafter.
4.4.3 Freezing and thawing of PCLS
For cryopreservation, I used 10% DMSO diluted in DMEM/F-12 medium. Each single
PCLS was placed in cryopreservation medium in individual cryovials and frozen at -80°C
(Nalgene Mr. Frosty Freezing Container, Thermo Scientific, MA, USA). Following
overnight freezing, each cryovial was transferred to liquid nitrogen for long-term storage
up to two weeks. On the day of the experiment, each cryovial was thawed rapidly in a
37°C water bath. The PCLS was then carefully removed and washed once in fresh culture
medium. (Figure 4.10)
4.4.4 Measurement of cytotoxicity using the lactate dehydrogenase
(LDH)-releasing assay
LDH releasing assay was performed using the CytoTox 96 non-Radioactive Cytotoxicity
Assay kit (Promega) according to the manufacturer’s instructions. Briefly, PCLS were
incubated for 18 hours in culture medium at 37°C. The amount of LDH released into the
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Figure 4.10: Schematic
of
freezing
and
thawing
protocol
for
PCLS.
culture supernatant was used to determine the number of dead cells. Using the culture
supernatant, cell death was quantified using a standard enzyme-linked immunosorbent
assay (ELISA) for LDH implemented at an optical density of 490 nm (SpectraMax M5,
Molecular Devices). These measurements were normalized to total number of cells in the
PCLS that were obtained in a representative set through standard procedures of lysis and
sonication.
4.4.5 Measurement of cell enzymatic activity
An MTT assay was performed using a Vybrant MTT Cell Proliferation Assay Kit (Life
Technologies, CA, USA). Briefly, PCLS were incubated for 3 hours in culture medium
containing 500 ng/mL MTT. The culture medium was then replaced with 100% DMSO
and the amount of dissolved formazan was quantified by examining the supernatant at an
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absorbance of 540 nm.
4.4.6 Preparation and immunohistology of PCLS thin sections
Never frozen and frozen-thawed PCLSs were fixed in 4% paraformaldehyde/PBS for 20
minutes. After washes with PBS, fixed PCLS were cryoprotected by immersion in 30%
sucrose/PBS overnight. PCLSs were then embedded in OCT and sections 10 microns
thick were collected. Sections of PCLSs were immunostained with antibodies against the
lung epithelium marker CC10 (1:500, T-18, Santa Cruz) and alpha-smooth muscle actin
(SMA) (1:500, MS-113, Thermo Scientific) using an established protocol [165].
Antigen-antibody complexes were detected by chromogenic substrates.
4.4.7 Live/dead staining and imaging of PCLS
The viability of the PCLS was tested using a commercially available kit (LIVE/DEAD kit
L-3224, Molecular Probes, OR, USA). Briefly, the PCLS was stained with 4 mM
calcein-AM and 2 mM ethidium homodimer-1 in HBSS with calcium and magnesium,
incubated at 37°C for 30-45 min, and imaged on an inverted microscope, using a GFP
filter (BP 470/40) for calcein-AM and a Cy3 filter (BP 545/30) for ethidium
homodimer-1 (DMI6000B, Leica Microsystems, IL, USA).
4.4.8 Measurements of airway contraction and relaxation
Using a ring of nylon mesh and a stainless steel washer, each PCLS was secured in place
within a 12-well plate. The multi-well plate was mounted on a computer controlled
translation stage and imaged using an inverted microscope (Leica Microsystems,
DMI6000B, IL, USA). Intact airways were selected for imaging, and PCLS were
incubated sequentially with increasing doses of methacholine (MCh) 10-⁷ M, 10-⁶ M,
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10-⁵ M, and 10-⁴ M (Sigma Aldrich, St. Louis, MO) for 5 minutes each, followed by 1mM
chloroquine (ChQ, Sigma Aldrich) for 10 minutes. Each airway was maintained in the
same plane of focus and imaged every minute for a total duration of 35 minutes. From
the acquired images, I quantified airway luminal area (Image J, NIH), and normalized its
magnitude to the pre-treatment baseline value. From the normalized data, I picked those
values corresponding to maximum constriction with each dose of MCh and maximum
dilation with ChQ.
4.4.9 Statistics
For reasons addressed in the discussion, fractional changes of airway lumenal area of
never-frozen PCLS (n=57 airways) versus frozen-thawed PCLS (n=46 airways) were
compared using a Mann-Whitney-Wilcoxon rank-sum (MWW) test [134]. Diﬀerences
were considered significant when p<0.05. All data are reported as mean and SEM.
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5
Zyxin in Static CellMechanics andCell Responses
to Stretch
In response to a spontaneous deep inspiration, contracted airway smooth muscle
(ASM) fluidizes rapidly and then resolidifies slowly, but molecular mechanisms
accounting for these salutary bronchodilatory responses –and their dramatic breakdown
in asthma– are unknown. I will show here that both the baseline contractile force and the
fluidization response of ASM are independent of the cytoskeletal protein zyxin, but the
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resolidification response is zyxin-dependent.
5.1 Introduction
Cells in tissues as diverse as the lung, gut, bladder, great vessels, and kidneys experience a
repeating sequence of transient mechanical stretches [5, 166–169]. Despite diﬀerences
in structure and function, various cell types within these tissues show the very same
physical response to stretch. Specifically, previous work has established that all cell types
exhibit: 1) a rapid fluidization of the cytoskeleton marked by the disappearance of actin
stress fibers and traction forces exerted by the cell upon its substrate, followed by 2) a
gradual and ATP-dependent resolidification of the cytoskeleton marked by recovery of
both actin fibers and traction forces to baseline levels [5, 25, 170]. Prior work to
determine mechanism has shown that F-actin stabilization or depolymerization, myosin
inhibition, and calcium depletion all act to change actin stress fibers and traction forces at
baseline as expected, but fail to fundamentally alter responses to stretch [5]. Molecular
mechanisms underlying this phenomenon remain poorly characterized.
The cytoskeletal protein zyxin is a key player in the repair and maintenance of actin stress
fibers [32, 115]. Zyxin relocalizes from the focal adhesions to actin stress fibers,
particularly in the presence of an external mechanical stress on the cell [31, 32]. Zyxin is
also necessary for the cytoskeletal reinforcement that follows mechanical stress, which
further suggests that zyxin may also play a role in the rapid recovery of actin stress fibers
following stretch [31]. Intriguingly, both the observed repair of stress fibers by zyxin and
the resolidification of the cytoskeleton following stretch occur on the timescale of a few
minutes [5, 25, 32]. This empirical evidence led to the hypothesis that zyxin may have a
critical role in cytoskeletal resolidification following stretch-induced fluidization.
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While fluidization and resolidification are universal responses, I focus here on the airway
smooth muscle cell, as regulation of the stiﬀness and contractility of airway smooth
muscle (ASM) in the presence of stretch is of key importance in the pathophysiology of
asthma [5, 11, 25, 171, 172]. Wherever possible, I used primary ASM cells, both from
wild type and zyxin =  mice as well as a siRNA-mediated knockdown of zyxin in human
ASM cells. In some cases where suﬃcient quantities of primary airway smooth muscle
cells could not obtained, I used instead the murine embryonic fibroblast (MEF), a
mesenchymal cell type which has a similar contractile apparatus composed of actin stress
fibers. With these model systems, I measured baseline stiﬀness and cell contractile force,
cytoskeletal remodeling rates and responses to stretch. From these studies, I found that
while under isometric conditions, zyxin played little role in determining cell mechanical
properties, under dynamic conditions, zyxin acted to stabilize the cell contractile
apparatus.
5.2 Results
5.2.1 Followinga single isotropiccell stretch, zyxinrecruits to sites
of actin SF fragmentation
Although changes in zyxin localization in response to high-frequency cyclic stretches
have been reported previously [31], physiologic responses such as net cellular contractile
force and responses to a single transient stretch of physiological magnitude and duration
have not yet been reported. In order to measure protein dynamics immediately following
a single stretch, in collaboration with Rama Krishnan and Mark Smith, we adapted the
system of Krishnan et al. [25] to work with high-resolution confocal microscopy.
Zyxin =  MEFs rescued with GFP-zyxin were transfected with LifeAct [115] and
subjected to a single transient isotropic stretch and unstretch of 10% strain amplitude and
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Figure 5.1: Zyxin is widely recruited to sites of actin SF fragmentation following single isotropic
stretch. Representative images showing localization of actin and zyxin before, and 50, 200, and 600
seconds after a single isotropic stretch. Scale bar for large images is 30 µm, and for insets is 5 µm.
4 second duration, as in a DI. At baseline, zyxin was predominantly localized at focal
adhesions (Figure 5.1). Within 50 seconds after completion of this maneuver, however,
zyxin began to localize predominantly along actin SFs (Figure 5.1) and persisted on SFs
for more than five minutes, which is a timescale reminiscent of ASM resolidification after
stretch-induced fluidization [5, 25]. Punctate bands of zyxin corresponded with local
decreases in LifeAct-actin intensity (Figure 5.2), thus establishing that even a single
transient stretch of physiological magnitude is suﬃcient to cause zyxin to recruit rapidly
to sites of imminent SF failure [32].
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Figure 5.2: Zyxin localizes to and stabilizes actin stress ﬁbers following stretch. (A) Kymograph of
actin and zyxin on a representative stress ﬁber following a single isotropic stretch. (B) Quantiﬁcation of
actin and zyxin intensity on a representative stress ﬁber following a single isotropic stretch.
5.2.2 Inthezyxin = MEF,baselinestiffnessandnetcontractileforce
aresimilartothatofrescuedMEFs, buttherateofcytoskeletal
remodeling increases
To what extent does zyxin influence cellular mechanical properties, either statically or
dynamically? To answer this question I first assessed the rate of remodeling within the
stress fiber. To do this I quantified the spontaneous nano-scale motions of a microbead
to which the stress fiber is firmly attached; because the microbead can barely move unless
the associated stress fiber remodels, such motions can be taken as a reporter of the rate of
internal stress fiber reorganization [5, 35]. Microbeads (5 µm) were coated with the
peptide sequence RGD, which binds avidly to integrins [35]. These beads were added to
cultured adherent MEFs, which bound the beads and formed focal adhesions with
associated stress fibers. The measured nano-scale motions of these beads were 45% larger
in the beads attached to zyxin =  MEFs than those attached to the GFP-zyxin rescued
MEFs (Figure 5.3), thus indicating that zyxin caused a modest but systematic slowing in
the rate of cytoskeletal remodeling (Figure 5.3), as if stabilizing cytoskeletal structures.
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Figure 5.3: Zyxin-/- MEFs show an increased cytoskeletal remodeling rate. MSDs of microbeads
adherent to the cytoskeleton in zyxin =  (n=739) and GFP-zyxin-rescued (n=844) MEFs show that
zyxin =  cells have a somewhat increased rate of remodeling, as evidenced by the upward shift of
the MSD curve.
But when I examined isometric cell stiﬀness using optical magnetic twisting cytometry
probed through these same beads [160] in zyxin =  versus GFP-zyxin rescued MEFs, I
found no diﬀerence in stiﬀness (Figure 5.4). Similarly, when I measured net contractile
force generated by each cell using traction force microscopy [36], I found no diﬀerence
in baseline net contractile moment (Figure 5.5). For the zyxin =  compared with the
zyxin-rescued MEF, peak tractions corresponding to the highest quartile of local
tractions become systematically attenuated, but with no change in whole-cell net
contractile moment, thus suggesting a change in intracellular spatial distribution [32].
Here I found, further, that while zyxin contributed appreciably to slowing and stabilizing
the rate of cytoskeletal remodeling, zyxin contributed little to isometric stiﬀness or
isometric contractile force, suggesting either that zyxin played at most only a slight role in
these static mechanical properties of the MEF or that other proteins somehow
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Figure 5.4: Zyxin does not contribute to isometric stiﬀness of the MEF. Across a wide range of bead
twisting frequencies, GFP-zyxin-rescued (n=261) and zyxin =  (n=273) MEFs show no diﬀerence in
isometric stiﬀness.
compensated for zyxin’s absence.
5.2.3 Theabsenceofzyxinalterscellmechanicalresponsestochanges
in the stiffness of themicroenvironment
It is well known that cells respond to the mechanical properties of their
microenvironment, and that changes in the stiﬀness of a cell’s microenvironment can
result in that cell changing its stiﬀness or contractile force [173–175]. I sought to
determine whether zyxin plays a role in determining a cell’s mechanical response to
changes in substrate stiﬀness using the zyxin =  MEF. I found that zyxin appears to
blunt the change in cell contractile force in response to changes in substrate stiﬀness.
Over an order of magnitude increase in substrate stiﬀness, wild type MEFs show on
average a fifteen-fold increase in cell contractile force, while zyxin =  MEFs show only a
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Figure 5.5: Zyxin =  and zyxin-rescued MEFs show no diﬀerence in baseline contractile force.
Net contractile moment is unchanged between the GFP-zyxin-rescued and zyxin =  MEFs. Circles are
individual cellular net contractile moment, black bars are means, and error bars are standard deviation
(n=34 zyxin-rescued, n=38 zyxin = ; p=0.4).
four-fold increase in cell contractile force (Figure 5.6). Additionally, on the softest
substrates I tested with a Young’s modulus of only 1.2 kPa, zyxin =  MEFs exert
significantly more force than wild type MEFs (Figure 5.6). These results suggest that
zyxin may play a key role in transducing mechanical cues from a cell’s microenvironment
and guiding accompanying shifts in cell contractile force.
5.2.4 Mechanical responses of zyxin =  and zyxin-rescued MEFs to
contractile agonist stimulation are incongruent
As zyxin is known to be an actin regulatory protein, I sought to determine whether zyxin
contributed to the cell mechanical response to contractile agonist stimulation. To test
this in the MEF, I chose fetal bovine serum (FBS) as an agonist as it is known to be a
potent inducer of cell contractility in the fibroblast [176–178]. When I examined
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Figure 5.6: The relationship between cell net contractile moment and substrate stiﬀness is blunted
in zyxin =  MEFs. Baseline cell net contractile moment versus substrate stiﬀness in wild type and
zyxin =  MEFs. When plated on 1.2 kPa gels, zyxin =  MEFs have signiﬁcantly higher average net
contractile moment than wild type MEFs (p<0.05).
changes in cell stiﬀness following treatment of serum-starved zyxin-rescued and
zyxin =  MEFs with FBS, I found that while both types of cell plateaued at an
approximately 50% increase in stiﬀness, the initial spike in stiﬀness following FBs
addition was much higher in zyxin-rescued MEFs (Figure 5.7). Zyxin-rescued MEFs
showed a maximum increase in stiﬀness of over 150%, while zyxin =  MEFs showed a
maximum increase in stiﬀness of only about 80% (Figure 5.7).
As changes in cell stiﬀness generally correlate with changes in cell traction force [34], I
sought to confirm this result by measuring changes in contractile force following
contractile agonist stimulation with FBS. In contrast, here I found a paradoxical result. In
the zyxin-rescued MEFs, by 300 seconds following FBS addition, net contractile
moment increased by 36% ± 11% (n=25; Figure 5.8). However, in zyxin =  MEFs, net
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Figure 5.7: Zyxin-rescued and zyxin =  MEFs show a similar increase in cell stiﬀness in response
to serum stimulation. While zyxin-rescued MEFs show a higher initial spike in stiﬀness in response to
serum stimulation, both zyxin-rescued (n=277) and zyxin =  (n=284) MEFs plateau to the same 50%
increase in cell stiﬀness.
contractile force increased by 78% ± 22% over this time period (n=34; Figure 5.8), and
the increase was significantly more than that of zyxin-rescued MEFs at 100 and 200
seconds following serum addition (p<0.5; Figure 5.8) and trended significant at 300
seconds (p=0.1; Figure 5.8). This represents an unresolved paradox, as one would
normally expect that traction force findings would correlate with cell stiﬀness findings. A
possible hypothesis explain these findings is that, in the MEF following FBS addition, the
changes driving increases in stiﬀness and those driving increases in contractility are
acting through diﬀerent pathways that involve zyxin in diﬀerent capacities. The
clarification and testing of this hypothesis is a subject for future work in the field.
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Figure 5.8: Zyxin =  MEFs (n=34) show a larger and faster increase in cell contractile moment
than zyxin-rescued MEFs (n=25) in response to serum stimulation.
5.2.5 In the MEF, resolidification responses to stretch show less de-
pendence on substrate stiffness in the absence of zyxin
In order to look at the relationship between substrate compliance and responses to
stretch, I measured the contractile response to stretch in wild type and zyxin =  MEFs
on substrates spanning an order of magnitude of stiﬀness, from 1.2 to 11 kPa. In these
experiments, I tested the hypothesis that zyxin drives mechanosensing of substrate
stiﬀness in a dynamic environment, rather than the static measures examined in the
above experiments. When MEFs were plated on substrates with Young’s modulus of 11
kPa and stretched with 5% strain, I found that wild type MEFs trend towards greater
resolidification than zyxin =  MEFs, although this finding fell short of statistical
significance (Figure 5.9). Additionally, I found that both wild type and zyxin =  MEFs
fail to resolidify following larger physiologic stretches of approximately 10% strain
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Figure 5.9: While shy of statistical signiﬁcance, zyxin =  MEFs trend towards less complete reso-
lidiﬁcation following transient stretch. Wild type (n=16) and zyxin =  (n=22) MEFs plated on 11 kPa
gels were subjected to stretches of approximately 5% strain. Measures of contractile moment before and
after showed that zyxin =  MEFs trended towards a less complete resolidiﬁcation, although this ﬁnding
was not signiﬁcant (p=0.1).
(Figure 5.10). It is possible that this cell type is not as robust to large strains as other cell
types previously studied [5], and ultimately this finding limited the stretch experiments
in MEFs to lower strain amplitudes. When I tested cell responses to 5% stretch across a
range of substrate stiﬀnesses, I found that wild type MEFs resolidify fully in locally stiﬀer
environments, while they fail to resolidify to baseline levels of traction in softer
environments (Figures 5.9, 5.11, 5.12). Zyxin =  MEFs showed the same diminished
resolidification across a tenfold range of substrate stiﬀness(Figures 5.9, 5.11, 5.12),
suggesting a role for zyxin in dynamic mechanosensing. These findings indicate that
there may be a relationship between substrate stiﬀness and resolidification following
stretch in MEFs that is dependent on zyxin.
66
1.2
1.0
0.8
0.6
0.4
0.2
0.0
N
e
t
 
C
o
n
t
r
a
c
t
i
l
e
 
M
o
m
e
n
t
(
N
o
r
m
a
l
i
x
e
d
 
t
o
 
B
a
s
e
l
i
n
e
)
6004002000
Time (seconds)
 WT MEF
 Zyxin
-/-
 MEF
Figure 5.10: MEFs are unable to recover traction forces following transient stretches of 10% mag-
nitude. wild type (n=9) and zyxin =  (n=9) MEFs ﬂuidize but do not resolidify with higher strains.
Figure 5.11: On softer substrates, both wild type and zyxin =  MEFs fail to reach their baseline
net contractile moment following transient stretch. Following a single transient isotropic stretch, wild
type (n=11) and zyxin =  (n=8) MEFs plated on 1.2kPa (A) or 4 kPa (B) polyacrylamide gels plateaued at
net contractile moments well below their baseline.
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Figure 5.12: The extent of resolidiﬁcation after transient stretch is dependent upon substrate stiﬀ-
ness in wild type but not zyxin =  MEFs Across an order of magnitude of substrate stiﬀness, the
degree of resolidiﬁcation after stretch-induced ﬂuidization in wild type MEFs ranged from 34% ± 5% on
the softest substrate to 86% ± 17% on the stiﬀest substrate. Zyxin =  MEFs showed the same degree
of resolidiﬁcation of approximately 60% across the tested range of substrate stiﬀness.
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Figure 5.13: Knockdown of zyxin in primary human ASM cells results in greatly decreased pro-
tein expression. Western blot of zyxin and actin at 72 hours shows an 88% ± 10% decrease in protein
expression.
5.2.6 In thehumanASMcell after zyxin knockdown, baseline stiffness
and responsiveness to histamine are unchanged, but the rate of
cytoskeletal remodeling increases
In the adherent primary human ASM cell in culture I used siRNA to achieve 91% ± 2%
reduction in zyxin mRNA at 48 hours (Figure 5.13), and noted 88% ± 10% reduced
protein expression at 72 hours (Figure 5.14). Using nano-scale bead motions as a metric
of remodeling rate, as above, I found that the zyxin-knockdown human ASM cells had a
similarly increased rate of remodeling (Figure 5.15). When I treated these cells with the
contractile agonist histamine [10 µM], cell stiﬀness [71] increased 26-28% in both
zyxin-depleted and control cells with no significant diﬀerences between them (Figure
5.16). Baseline stiﬀness before contractile stimulation similarly showed no diﬀerence
(Figure 5.17). In primary human ASM cells as in MEFs, zyxin influenced remodeling
rates but not isometric cell stiﬀness.
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Figure 5.14: Knockdown of zyxin in primary human ASM cells results in greatly decreased zyxin
mRNA. qPCR of zyxin at 48 hours post-transfection shows a 91% ± 2% reduction in zyxin mRNA.
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Figure 5.15: Knockdown of zyxin results in an increase in cytoskeletal remodeling rate in primary
human ASM cells. The cytoskeletal remodeling rate is increased after zyxin knockdown as indicated by
the upward shift of the MSD curve (n=1054 with no siRNA, 1019 with scrambled siRNA and 1095 with
zyxin siRNA).
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Figure 5.16: Zyxin does not aﬀect the cell stiﬀening response to histamine in the primary human
ASM cell. Primary human ASM cell stiﬀening responses to histamine (added at 60 seconds) are un-
changed by zyxin knockdown (n=547 with no siRNA, 736 with scrambled siRNA and 761 with zyxin
siRNA). Time controls with HASM media added at 60 seconds show no increase in stiﬀness (n=239 with
no siRNA, 347 with scrambled siRNA and 356 with zyxin siRNA.
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Figure 5.17: Zyxin does not aﬀect isometric cell stiﬀness in the primary human ASM cell. Baseline
isometric stiﬀness is similar in control and zyxin knockdown HASMs (n=547 with no siRNA, 736 with
scrambled siRNA and 761 with zyxin siRNA).
5.2.7 In the isolated airway smoothmuscle cell, resolidification –but
not fluidization– is zyxin-dependent
In the ASM cell experiments above, conditions were purely static and isometric. In the
lung, by contrast, the microenvironment is highly dynamic; the ASM cell strains by
about 4% of its length with each tidal breath and as much as 10-25% of its length with
each spontaneous DI or sigh [2, 24]. While studies of zyxin =  mice have shown no
obvious physiologic defect [78], the role of zyxin in actin remodeling [31], repair [32]
and stabilization –as presented here– suggest that zyxin might play an important role in
the response to stretch-induced cytoskeletal fluidization or subsequent resolidification
[25]. Accordingly, working with Mark Smith at the Huntsman Cancer Institute, I
examined the role of zyxin in maneuvers approximating those dynamic events. In
isolated primary ASM cells from zyxin =  versus wild type (wild type) mice, western
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Figure 5.18: Western blotting conﬁrms the knockout of zyxin in primary ASM cells from the
zyxin =  mouse.
blot confirmed the absence of zyxin (Figure 5.18). After culturing these ASM cells on
gels of physiologic stiﬀness for 4 days without further passaging, we used traction
microscopy [36] to measure contractile forces before and after a single transient isotropic
stretch (Figure 5.19). In zyxin =  versus wild type primary ASM cells, there was no
diﬀerence in the net contractile moment prior to the stretch (Figure 5.20). Immediately
following a single transient stretch (5-10% strain), wild type ASM cells fluidized rapidly
and the net contractile moment [36] decreased dramatically, by 65% ± 6% (Figures 5.19
and 5.21). The contractile moment then gradually recovered completely over the next
300 seconds to 101% ± 7% of baseline (Figure 5.21). In response to imposed stretch,
zyxin =  cells showed a similar fluidization response (Figure 5.21). However, compared
with wild type cells, zyxin =  cells failed to resolidify to the same extent (Figure 5.21,
p<0.01). While the fluidization response and the early part of the resolidification
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Figure 5.19: Zyxin mediates post-ﬂuidization resolidiﬁcation in primary ASM cells. Representative
traction maps of wild type and zyxin =  primary ASM cells at baseline and 10, 50 and 300 seconds
after a single transient isotropic stretch.
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Figure 5.20: Baseline net contractile moment is similar in both zyxin =  and wild type primary
ASM cells. Circles are individual cellular net contractile moment, black bars are means, and error bars
are standard deviation (n=25 wild type, n=26 zyxin = ; p=0.3).
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Figure 5.21: Resolidiﬁcation following transient stretch is dependent on zyxin in primary ASM cells.
Normalized changes in net contractile moment in wild type (n=25) and zyxin =  (n=26) primary ASM
cells following a transient 5-10% stretch at time = 0 seconds. By 5 minutes post-stretch it is clear that
the zyxin =  ASM cells are not recovering their contractile force to the same extent as the wild type
ASM cells.
response tracked similarly, by 500 seconds this resolidification in zyxin =  cells stalled
and was only 73% ± 6% of baseline (Figure 5.21).
To simulate physiologic conditions even more closely, we stacked DIs at a frequency
approximating that observed during spontaneous breathing [2]. Within the 300 seconds
following each stretch, wild type ASM cells recovered to 81-97% of their baseline initial
contractile force whereas zyxin =  ASM cells recovered to only 63-70% (Figure 5.22,
p<0.05). At the level of the primary ASM cell, both the rate and the extent of
resolidification following transient stretch were clearly zyxin-dependent.
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Figure 5.22: Zyxin-dependence of resolidiﬁcation holds through a series of transient stretches.
Normalized changes in net contractile moment in wild type (n=22) and zyxin =  (n=23) primary ASM
cells following a series of three transient 5-10% stretches at 0, 310 and 620 seconds. Incomplete resolid-
iﬁcation of the zyxin =  ASM cells persists across the three stretches.
5.2.8 Zyxin expression levels are similar in asthmatic and normal hu-
manASMcells
Based on the results I found in murine and human ASM cells showing the role of zyxin in
regulating dynamic cell mechanical properties, I sought to examine whether ASM from
normal and asthmatic humans had similar levels of zyxin expression. Accordingly, I
cultured ASM cells from three normal and three asthmatic donors and used western
blotting to detect zyxin protein expression. While there was significant variation of zyxin
expression in ASM cells between the diﬀerent donors, there were no systematic
diﬀerences in expression of zyxin between the normal and asthmatic human ASM cells
(Figure 5.23A, B). Based on this, and the lack of evidence from genome-wide association
studies on asthma for any SNPs on or near the zyxin gene locus [179–181], it seems
likely that there are not systematic diﬀerences in zyxin expression between normals and
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Figure 5.23: There is no systematic variation in zyxin protein expression between normal and asth-
matic ASM. Western blot of zyxin and actin in primary human ASM cells from normal and asthmatic
donors.
asthmatics.
5.3 Discussion
From these experiments, I concluded that zyxin plays only a small role in determining the
mechanical nature of the isolated ASM or MEF cell under isometric conditions, but plays
a substantial role in determining the mechanical nature of the isolated ASM or MEF cell
under dynamic conditions. This is most apparent in the case of isotropic stretch of the
isolated cell, where the absence of zyxin results in the failure of the ASM cell to resolidify
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fully.
5.3.1 The contribution of zyxin to cytoskeletal remodeling rates
Recent work on ASM mechanics has established the hypothesis that the material
properties of ASM are reminiscent of those of soft glassy material [23, 160, 182, 183].
The kinetics of actomyosin interactions cannot fully explain the dynamics of ASM
[23, 183], but instead several properties of ASM can only be adequately explained by
treating the ASM as a soft glassy material. One of these properties is the nature of the
microscale rearrangement of the cytoskeleton in the ASM cell [35]. In the ASM cell,
rearrangements of the cytoskeleton are subdiﬀusive over short time scales and
superdiﬀusive over longer time scales; over short time scales the molecules are trapped or
caged in the crowed intracellular space, while over longer time scales these molecules are
actively rearranged in an ATP-dependent manner [35]. However, depending on the
circumstances of the cell, these superdiﬀusive behaviors can exhibit faster or slower rates
[5, 35], which are indicative of the cell being in a more fluid-like or more solid-like
(jammed) state. Here I measured these cytoskeletal remodeling rates in the isolated
MEF and the human ASM cell and found that cells lacking zyxin exhibit faster
remodeling rates (Figures 5.3, 5.15). This indicates that zyxin decreases the fluidity of the
cells, likely by stabilizing existing stress fibers and thereby inhibiting microscale
cytoskeletal rearrangements [32]. Based on the previously discussed soft glassy material
hypothesis of ASM and bronchospasm, this suggests that zyxin could, in fact, contribute
to the frozen ASM state that precipitates bronchospasm [23].
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5.3.2 Possible downstream effects of zyxin in response to stretch
As zyxin is known to localize to the nucleus and appears to influence protein
transcription, these studies were limited to immediate responses following mechanical
stimuli [184–188]. In this way, any influence of further downstream eﬀects in response
to stretch caused by the absence of zyxin acting to aﬀect transcription are not at issue, as
these changes occur on a timescale of several minutes to hours [189]. Instead, by
focusing on the first few minutes following stretch, I was able to examine primarily the
impact of zyxin on the actin cytoskeleton, to which it localizes rapidly following
mechanical perturbation [32]. However, should zyxin be shown to instigate further
changes in protein expression in response to stretch, it is possible that zyxin may play a
role in the ASM cell’s long term adaptation to its dynamic mechanical environment. This
would then merit further study in the zyxin =  mouse in vivo.
5.3.3 As airway smoothmuscle resolidification after stretch is zyxin-
dependent, theremaybe arole for zyxin in the integratedairway
This work demonstrates that zyxin only plays a small role in regulating cell mechanics
under isometric conditions. While previous studies have shown that the absence of zyxin
alters the distribution of traction forces within the isolated cell [32], the absence of zyxin
has not been found to alter the baseline net contractile moment or isometric stiﬀness of
the isolated cell. However, zyxin does contribute substantially to the control of cellular
contractility under dynamic conditions, as resolidification of the ASM following stretch
is dependent on zyxin. This presents the question as to whether these observations exist
only in the isolated cell or whether they scale across levels. To answer this question
requires an exploration of the role of zyxin in the integrated airway, which is the subject
of the next chapter.
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5.4 Materials andMethods
5.4.1 Cell lines and cell culture
Derivation and immortalization of embryonic fibroblasts from zyxin =  mice was
described previously [81]. These zyxin =  fibroblasts were stably rescued with
N-terminally tagged zyxin by viral infection followed by FACS sorting to select cells
expressing GFP-tagged zyxin [78]. Primary airway smooth muscle cells were isolated
from the tracheas of wild type and zyxin =  mice as described previously [71, 190] and
cultured on soft polyacrylamide gels without further passaging. Human ASM cells were
obtained from R. Panettiere (University of Pennsylvania) and cultured in Ham’s Nutrient
Mixture F-12 medium supplemented with 10% fetal bovine serum (FBS), 100 U ml-1
penicillin, 100 µg ml-1 streptomycin, 200 µg ml-1 amphotericin B, 12 mM NaOH,
1.6 mM CaCl2, 2 mM l-glutamine and 25 mM HEPES.
5.4.2 Live-cell imaging for protein dynamics studies and analysis
Imaging of MEFs was performed on PDMS gels coupled to 200 nm fluorescent beads
and fibronectin. Images were collected every 10 seconds on an inverted Nikon Tie
(Nikon Instruments) equipped with either a Nikon 20X Plan Apo NA .75 dry, or a Nikon
40X Apo LWD NA 1.15 water immersion lens. This system also utilized an Andor
spinning disk confocal (Andor Technology) and an Andor Ixon 885 EMCCD camera.
Automation and image capture utilized Andor IQ software running on a Hewlett Packard
workstation. [115]. Working with my collaborators, Mark Smith and Rama Krishnan, we
adapted this system to apply mechanical stretches by designing a small annular punch
indenter that fits on the condenser and could be lowered to the surface of the gel [25].
Stretch was applied using a condenser mounted annular indenter. The final positioning
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and application of stretch were done by precise movement of the stage in Z with a Piezo
stage insert. Following each experiment, an additional stretch was applied to verify the
magnitude of stretch applied.
5.4.3 Opticalmagnetictwistingcytometry,beadtrackingandanalysis
Cells were plated for 24 hours to spread and form mature focal adhesions and then were
serum starved for a further 24-48 hours. RGD-coated 5 µm iron microbeads were added
and incubated for 20 minutes to allow the cells to form focal adhesions on the beads. The
RGD-coated beads were magnetized and subjected to torque from a 30G magnetic field
across a range of frequencies to collect measures of cellular stiﬀness. Lateral bead
displacements were collected and used to calculate stiﬀness as previously described
[124, 182]. To measure cytoskeletal remodeling, spontaneous bead motions were
recorded. The overall rate of remodeling was quantified by the mean square displacement
(MSD) over changes in time as described previously [35, 124].
5.4.4 RNA interference
HASM cells were plated overnight and then transfected with either a pool of 4
non-coding siRNAs (ON-TARGETplus Non-targeting Pool Catalogue
#D-001810-10-05, Dharmacon, PA, USA) or 4 zyxin-targeted siRNAs
(ON-TARGETplus SMARTpool - Human ZYX Catalogue #L-016734-00-0005,
Dharmacon) at a concentration of 25 nM using a transfection reagent at a concentration
of 0.2% by volume (DhamaFECT 1 siRNA Transfection Reagent Catalogue #T-2001-02,
Dharmacon). Q-PCR assay of transfection eﬃciency was performed at 48 hours and
protein knockdown confirmed by western blot at 72 hours. All experiments were
performed at 72 hours to ensure adequate protein knockdown.
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5.4.5 Single-cell traction forcemicroscopy and stretch
Primary ASM (and MEF) cells were plated on 4 kPa polyacrylamide gels with 200 nm
fluorescent beads and allowed to adhere and stabilize over 96 hours (48 hours for MEFs).
As described previously in Butler et al. [36], the traction field was calculated from a
displacement vector map of changes in bead positions using Fourier transform traction
microscopy (FTTM). This field was used to calculate the net contractile moment of the
cell. Stretch experiments were conducted as follows: baseline images of the cell and
beads were recorded and then homogeneous isotropic stretch of between 5% and 10%
strain was applied. Bead images were collected every 10 seconds for 10 minutes following
stretch (or for 15 minutes in the case of the multiple stretch experiment), followed by a
final reference image of the gel after the cell’s removal by trypsin. Stretch was applied
with an annular indenter as described in Krishnan et al. [25].
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6
Zyxin in the Integrated Airway
In the previous chapter, I demonstrated at the level of the isolated airway
smooth muscle (ASM) cell that zyxin does not alter isometric contractile force but
does alter the pace and the extent of force recovery after a dynamic stretch that mimics a
deep inspiration (DI). In this chapter, I will show at the level of the integrated airway in
the murine precision cut lung slice (PCLS) that, similarly to findings at the cellular level,
zyxin does not alter airway narrowing in response to methacholine in the absence of DIs.
Similarly, I will also show that in response to DIs, the pace of the bronchodilation is
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strongly dependent on zyxin. However, in contrast to results at the cellular level, the
overall magnitude of that integrative response is not dependent on zyxin. These data thus
reveal a remarkable incongruence between cellular and integrated airway responses to
stretch that remains unexplained. Compensatory developmental events in the zyxin = 
airway cannot be ruled out.
6.1 Introduction
As previously discussed in Chapter 1, the most eﬀective of all known bronchodilators is
the stretch of airway smooth muscle (ASM) that results from a simple deep inspiration
(DI) [1, 3, 3, 191, 191]. During an asthmatic attack, however, this important mechanism
fails [10–12, 192]. Related hallmarks of asthma include not only increased contractile
stimulus of ASM but also increased ASM mass [14, 15], increased airway wall thickness
[13, 193], and decreased lung recoil [16, 194]. Acting alone or in concert, these factors
cause ASM to stretch less with each breath [12, 17], which allows it to become stiﬀer still,
until eventually a tipping point is reached beyond which the ASM can become so stiﬀ
that it is virtually frozen [20] and therefore no longer stretches with each breath
[19, 27, 195]. ASM would thereafter remain refractory to the beneficial eﬀects of deep
inspirations, stuck in a shortened state until the contractile stimulus is removed or
bronchodilator drugs take eﬀect. This mechanistic framework provides a plausible
biophysical basis to explain why the eﬀects of deep breathing are so eﬀective in the
normal lung but become blunted in the asthmatic lung. However, the molecular
mechanism responsible for this diﬀerence remains less clear.
The work described in Chapter 5 of this thesis indicated a candidate molecule for the
dynamic regulation of ASM contractility: zyxin. Zyxin is a focal adhesion protein known
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to be involved in the regulation of the actin cytoskeleton, primarily through the
stabilization and repair of actin stress fibers [32]. Zyxin is also known to be
mechanoresponsive, localizing to actin stress fibers in response to cylic uniaxial stretch or
local mechanical stimulation [31, 32, 82]. In the previous chapter of this thesis, zyxin was
shown to be necessary for the normal resolidification response to stretch; zyxin =  ASM
cells did not return to their baseline contractile force within the same timeframe as wild
type ASM cells, but instead plateaued at around 75% of baseline force. Importantly, I also
found that zyxin aﬀected only cellular contractile force in response to stretch, and not
baseline contractile force or responsiveness to contractile stimuli. I therefore proposed
that zyxin works dynamically, but not statically, to stabilize the contractile apparatus in
ASM.
Based on these interesting results, I sought to test whether these observations at the level
of the isolated ASM cells translated to the level of the integrated airway. To address this
issue, I chose the murine precision cut lung slice (PCLS) as a model system because it
preserves the multicellular composition and much of the structural organization of the
lung [37, 38, 142]. As described in the pioneering work of Sanderson, the PCLS also
allows for direct microscopic observation of individual airway responses to various
stimuli including contractile agonists and mechanical stretch [37, 38, 129, 142]. Using
PCLS from wild type and zyxin =  mice, I measured contractile responses to
methacholine and subsequent airway dilation during a series of imposed stretches. I
found that while the magnitude of airway dilation with cyclic stretch was
zyxin-independent, the dynamics of airway dilation were strongly zyxin-dependent, with
airways from zyxin =  mice dilating more rapidly than airways from wild type mice.
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6.2 Results
6.2.1 Using PCLS to probe airway responses to stretch
To compare responses at the level of the SF and the isolated cell, as described in Chapter
5, to responses at the level of the integrated murine airway, we used the precision cut lung
slices (PCLS) [8, 37] obtained from wild type and zyxin =  mice. In brief, the freshly
excised lung is filled with agarose, cooled, allowed to gel, and then sliced to a uniform
thickness of 250 µm. When re-warmed and placed upon a polyacrylamide gel, small
airways embedded within the lung parenchyma are readily visualized, remain highly
contractile in response to agonist, and can be stretched in a simple manner (Figure 6.1)
so as to simulate the tidal action of breathing and DIs [8, 37]. Another important
advantage of the PCLS is as follows. In the isolated cell, as described above, the extent
and timing of cell stretch is imposed and controlled in a manner that is insensitive to the
mechanical properties of the ASM cell itself, and, as a result, the positive mechanical
feedbacks described above are rendered inoperative. But in the PCLS the extent and
timing of lung parenchymal expansion is imposed and controlled in a manner intended
to mimic a spontaneous DI in vivo. Much as conditions in vivo, were the ASM relaxed and
limp, airway strain would follow closely that of surrounding lung parenchyma, but were
the ASM contracted and stiﬀ, as the surrounding lung parenchyma expands the airway
might become so stiﬀ as to strain hardly at all. Consequently, the resultant stretch of the
embedded and integrated airway smooth muscle cell is set in large part by the airway
smooth muscle itself, its stiﬀness, and the dynamic load against which that muscle is
contracting. When these factors dictate that ASM become fluidized and soft [4, 5], it
follows that stretch induces stretch. In this preparation –as in the living, breathing lung–
positive mechanical feedbacks are therefore enabled. In this study, airways in PCLS were
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Figure 6.1: Applying stretch to the murine PCLS. (A) Schematic of the annular indenter used to stretch
PCLS (not to scale). (B) Cut-through view of the indenter causing the conﬁned gel to bulge and stretch
the PCLS (not to scale). Arrows indicate stretch of PCLS.
Figure 6.2: Experimental design to contract and stretch airways in PCLS. Experimental timeline of
MCh dose-response and stretch, red bars indicate image acquisition.
first contracted using increasing doses of methacholine. Once airways were maximally
contracted, cyclic isometric stretch was applied to a subset of the airways and dilation
responses were recorded (Figure 6.2).
6.2.2 Airwaycontractileresponsestomethacholinearezyxin-independent
In the absence of parenchymal strains, as methacholine concentration increased, airway
lumenal area decreased in both wild type and zyxin =  airways (Figure 6.3). In line with
previously reported studies in C57BL/6 animals [164], wild type airways showed a mean
decrease in airway lumenal area of 37% ± 3% with 10-⁴ M MCh, which was not
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Figure 6.3: MCh responses are similar in both wild type and zyxin =  airways. Representative
airways from wild type and zyxin =  animals, scale bar is 200 µm.
significantly diﬀerent from the decrease in lumenal area observed in zyxin =  airways
(Figure 6.4, p=0.12). This finding is in line with my finding in the previous chapter that
ASM responses to histamine are unchanged with zyxin siRNA knockdown. Previous
work has shown that the responsiveness of murine airways is size-dependent [39, 132].
While only small airways were used in this study, I examined the data for a possible eﬀect
of airway size, but did not find one. Controlling for the size of the airways did not aﬀect
the finding that responses to MCh are zyxin-independent (Figure 6.5).
6.2.3 Fluctuation-inducedrelengthening in the constricted airway in
themurine PCLS
In the presence of physiological parenchymal strains, the caliber of a constricted airway
increases and smooth muscle relengthens; this phenomenon is called
fluctuation-induced relengthening (FIR) [8, 196]. To measure FIR in the PCLS we used
the method of Krishnan et al. [25] and Lavoie et al. [8] to apply cyclic isotropic
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Figure 6.4: MCh responses are not signiﬁcantly diﬀerent between wild type and zyxin =  airways.
Normalized changes in lumenal area of airways from wild type (n=114) and zyxin =  (n=75) animals in
response to increasing doses of methacholine.
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Figure 6.5: No strong relationship was observed between airway size and MCh responsiveness.
Airways ranging 500 µm in diameter show similar distributions of maximum contraction. No diﬀerences
were observed between wild type (n=114) and zyxin =  (n=75), other than a somewhat higher number
of very large airways in the wild type group. However, both wild type and zyxin =  airways had similar
median and IQR of airway size.
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Figure 6.6: Airways in murine PCLS dilate with cyclic isometric stretch of the surrounding
parenchyma. Scale bar is 100 µm.
parenchymal strains targeting 10% linear amplitude once every 6 seconds for 5 minutes
(Figures 6.1, 6.2, 6.6). This applied parenchymal strain was transmitted eﬀectively to
airways on average, although, as expected from Lavoie et al [8], this degree of strain was
highly variable from airway to airway (Figure 6.7). In accordance with the findings of
Lavoie et al. [8], we also found a positive trend but not a significant relationship between
the local amplitude of airway tidal strain and the local FIR in the same airway in wild
type, but not in zyxin = , although this could be an eﬀect of small sample size (Figure
6.8). We found no relationship between the degree of initial constriction of the airway
and the subsequent magnitude of FIR in that same airway, however (Figure 6.9).
6.2.4 In the integrated murine airway, the rate of airway dilation in
response to a DI -–but not the final airway caliber–- is zyxin-
dependent
In response to these cyclic strains, reversal of bronchospasm by DIs varied greatly from
airway to airway, as expected based on previous studies [39, 164], with an average
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Figure 6.7: Applied strain to the lung parenchyma was transferred eﬀectively to the airways. Mean
strain transferred to airways with stretch indenter, bars are SEM (n=20 wild type, 14 zyxin =  airways).
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reversal of lumenal area of 40% ± 11% in wild type airways (Figures 6.6, 6.10).
Surprisingly, the magnitude of this reversal in the zyxin =  airway was 37% ± 14% and
was not diﬀerent than that observed in wild type (Figure 6.10, p=0.3). However,
zyxin =  airways achieved this relengthening much more rapidly. For example, in both
wild type and zyxin =  slices many airways dilated to more than 75% of their final steady
state airway with the first stretch, but a larger fraction of these were from zyxin = 
airways (Figure 6.11). Indeed, 79% of the zyxin =  airways dilated with the first stretch
to 75% of the final steady state area, whereas only 45% of wild type airways did so (Figure
6.11). Over the course of many stretches, the strong response to the first stretch together
with other innate heterogeneities caused these data to be distributed in time in a strongly
non-exponential, non-Gaussian, and noisy fashion (Figures 6.12, 6.13). This is not
entirely unexpected, as previous work has shown substantial heterogeneities in airway
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Figure 6.10: Reversal of bronchospasm with cyclic stretch was similar in wild type and zyxin = 
airways. No signiﬁcant diﬀerences in the magnitude of reversal of bronchospasm were observed be-
tween airways from wild type (n=20) and zyxin =  (n=14) animals.
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Figure 6.11: Percentage of airways reaching a given fraction of their ultimate steady state dilation
with a single stretch. A higher percentage of airways from zyxin =  animals (as compared to airways
from wild type animals) reach 25, 50, 75, and 90% of the ﬁnal steady state dilation in a single stretch.
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Figure 6.12: Histogram of reversal of bronchospasm observed in wild type and zyxin =  airways.
Y-axis indicates probability, 14 bins of 20% width.
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Figure 6.13: Cumulative probability function of percent reversal of bronchospasm in wild type and
zyxin =  airways.
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Figure 6.14: Airways in zyxin =  PCLS exhibit more rapid dilation following stretch. Times to
achieve 25%, 50%, 75%, and 90% of ﬁnal steady state dilation (black diamonds are median values,
whiskers are IQR). Airways from zyxin =  (n=14) animals have signiﬁcantly lower time constants to
reach each of these fractions than airways from wild type (n=20) animals (*p<0.05).
responses to contractile agonist stimulation and stretch [8, 93]. Nonetheless, the
Mann-Whitney rank sum test showed that the median time required for each airway to
dilate to 90% of its final steady state area (t90%) was smaller by half in zyxin =  versus
wild type airways (Figure 6.14; p<0.05), and that times were also significantly shorter in
zyxin =  airways to reach t25%, t50%, and t75% (Figure 6.14; p<0.05). At the level of the
intact airway embedded within the PCLS, zyxin did not change the extent of airway
lumen recovery following a sequence of DIs but did substantially slow the rate of that
recovery.
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6.3 Discussion
6.3.1 Mechanical stretch, deep inspirations and zyxin
In Chapter 5, I showed that resolidification of the ASM cell following stretch is
dependent on zyxin. However, I found the role of zyxin at the level of the integrated
airway to be paradoxical, with no diﬀerence observed in the magnitude of reversal of
bronchospasm. I did, however, observe that the dynamics of this reversal were strongly
zyxin-dependent, with airways from zyxin =  mice dilating more rapidly with cyclic
stretch. It remains unclear what accounts for these observed diﬀerences in response to
stretch between isolated ASM cells and ASM in the intact airway, although it is possible
that compensatory changes occur in the airway during development in the zyxin = 
mouse.
6.3.2 Docompensatoryeventsoccurduringdevelopmentinthezyxin = 
airway?
The preceding work reveals a paradox: in the isolated ASM cell, resolidification after
stretch was strongly dependent on zyxin, while in the integrated airway, the magnitude of
airway dilation with stretch was similar in both wild type and zyxin =  airways. One
hypothesis to explain this observation could be that the zyxin =  airway experiences
compensatory remodeling during the animals development. Previous work
characterizing the zyxin =  mouse examined primarily development of the nervous
system and skin architecture, where no diﬀerences were observed [33]. A detailed study
of airway structure has never been done in these animals.
However, it is quite possible that compensatory events occur during the development of
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the lung based on the evidence presented here that zyxin is a mechanoresponsive
regulator of dynamic contractility. Earlier work has shown that in many mammalian
species, including mice, mechanical stretch is implicated in normal lung development
both pre- and post-natally [197–201]. Several studies have shown that mechanical
stretch of the developing lung stimulates growth [197, 199, 201]. Additionally, previous
work looking at bronchial myogenesis in both mouse and human cells demonstrated that
stretch induces alternative splicing of the serum response factor protein, which is know to
trigger muscle-specific gene expression [200]. As zyxin is known to be involved in
transducing external mechanical stimuli to the cell [32, 78–80, 82, 202–204], I suggest
the hypothesis that the absence of zyxin during development alters these cues in the
developing airway, resulting in structural diﬀerences in the zyxin =  airway. If true, then
compensatory changes in the extracellular matrix composition of the airway basement
membrane or lung parenchyma, or in the size, number or organization of the ASM cells,
might resolve the paradox.
6.3.3 A phenotypic role for zyxin in themurine airway
At the level of the stress fiber and the isolated cell, both the pace and the overall
magnitude of the response were dependent upon zyxin. I show here that at the level of
the integrated PCLS the pace but not the overall magnitude of the dilation response is
dependent upon zyxin. Despite the paradoxical findings in the isolated cell versus the
integrated airway, this work nonetheless shows for the first time a phenotypic role for
zyxin in the murine airway. These findings demonstrate a clear role for zyxin in ASM
responses to dynamic mechanical strains as occur during spontaneous deep inspiration,
indicating that in the dynamic mechanical environment characteristic of the lung, zyxin
is a potential target to drive down contractility in ASM and attenuate bronchospasm.
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6.4 Materials andMethods
6.4.1 Animals
Lungs were obtained from four 16-week-old wild type and three 16-week-old zyxin = 
C57BL/6 mice. All mice used in this study were housed in a specific-pathogen-free
barrier facility and cared for, handled, and euthanized following guidelines approved by
the Institutional Animal Care and Use Committee of the University of Utah.
6.4.2 Precision cut lung slice (PCLS) preparation and culture
PCLS were prepared as described previously [37, 38]. Following tracheotomy, the
mouse lungs were insuﬄated with 1% low-melting point agarose in HBSS. The insuﬄated
lungs were then placed in cold HBSS (Corning Life Sciences, MA, USA). After the
agarose had formed a gel, the two largest lobes were separated and then sectioned into
250 µm thick slices using a Precisionary Instruments VF-300 tissue slicer. Lung slices
were cultured in 1:1 DMEM/F-12 supplemented with penicillin, streptomycin,
kanamycin, and amphotericin B (Invitrogen, MA, USA). Media was changed once an
hour for the first 4 hours. The PCLS were then frozen in the culture media supplemented
with 10% DMSO as described in Rosner et al. [39] and shipped on dry ice from Utah to
Boston where they were rapidly thawed and cultured in fresh culture media for at least 2
hours before experiments were performed.
6.4.3 Methacholine dose-response and stretch of airways in murine
PCLS
Using a ring of nylon mesh embedded in a PDMS ring, each PCLS was secured in place
on a 4 kPa polyacrylamide gel in a standard 6 well culture plate. The multi-well plate was
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mounted on a computer controlled translation stage and imaged using an inverted
microscope (Leica Microsystems, DMI6000B, with adaptive focus, motorized stage, and
stage incubator, IL, USA). Airways with an intact smooth muscle layer and a diameter
between 100 and 400 µm were selected for study. These airways were treated with 10-⁷
M, 10-⁶ M, 10-⁵ M, and 10-⁴ M methacholine (MCh, Sigma Aldrich, St. Louis, MO). A
subset of the airways was used to test responses to DI. The airways used in the stretch
experiments had to meet three conditions: first, the airways had to have visibly
contracted in response to MCh treatment (by approximately 80%); second, the airways
had to be far enough away from the edge of the lung slice that all of the annular indenter
would be in contact with the tissue when centered around the airway of interest; and
lastly, only one airway from each slice could be used as the stretching of one airway
would confound any results from the subsequent stretch of another airway in the same
slice. Each of these airways was stretched for 5 minutes with an annular indenter as
described in Lavoie et al. [8]. Briefly, an annular indenter was lowered until it
compressed the gel on which the PCLS lies, causing the confined gel to bulge and apply a
radial stretch to the lung tissue within the indenter (Figure 6.1). Each airway was imaged
every minute during the dose-response and stretch, except the first minute of stretch
where the airways were imaged every second (Figure 6.2). From the acquired images, we
quantified airway lumenal area (Image J, NIH), and normalized its magnitude to the
pre-treatment baseline value.
6.4.4 Statistics for airway responses
Where not otherwise noted, standard two-sided t-tests were used. The normalized
changes in lumenal area in airways in PCLS from wild type and zyxin =  animals were
compared using the Mann-Whitney-Wilcoxon rank-sum (MWW) test. We chose the
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MWW test instead of the more common t-test for this comparison because distributions
of airway lumenal area do not follow a normal distribution [134]. Diﬀerences with
p<0.05 were considered significant.
100
7
Conclusions and Implications
7.1 TheRole of Zyxin in Airway SmoothMuscleDynamics
Here we examined the role of zyxin during dynamic loading and across multiple scales
–stress fiber, isolated cell, and precision cut lung slice. The multi-scale approach is
important, because it is only when comparing across scales that certain consistencies, as
well as informative inconsistencies, become evident. At the level of the stress fiber within
the isometric zyxin =  versus GFP-zyxin-rescued MEF, there were diﬀerences in the
rate of remodeling (Figure 5.3) and in the rate of spontaneous stress fiber ruptures [32]
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but no appreciable diﬀerences in static cytoskeletal structure. Peak tractions under
particular focal adhesions depend upon zyxin [32], but the integrated whole-cell net
contractile moment under isometric conditions was not dependent on zyxin (Figures
5.5, 5.20). At the integrative level, similarly, the minimum airway caliber after exposure
to contractile agonist but before exposure to DIs was not dependent on zyxin (Figure
6.4). At each of these levels results were mutually consistent in the absence of DIs; in the
measures reported here zyxin played no role in the absence of a DI except in the case of
the rate of cytoskeletal remodeling.
In the presence of DIs, still other consistencies across scale became readily apparent. At
the cellular level the extent of fluidization of the ASM by a DI did not depend upon zyxin
(Figure 5.21) and, similarly, at the tissue level the extent of airway dilation, and
associated fluctuation-induced ASM relengthening, did not depend upon zyxin (Figure
6.10). Moreover, at both these levels, it was only the remodeling dynamics (Figures 5.3,
5.15) and the rate of recovery of contractile force, and not the isometric mechanical
properties, that were zyxin dependent (Figures 5.21, 5.22, 6.14). The data presented here
show that at the level of the stress fiber, the isolated cell, and the integrated airway, zyxin
stabilizes the contractile response during resolidification (Figure 7.1). These results
extend previous studies showing that zyxin exhibits rapid, force dependent recruitment
to actin structures, where it is essential for normal reinforcement, remodeling [31] and
repair [32] of cellular actin structure (Figure 7.2).
Consistencies across scale notwithstanding, certain inconsistencies across scale were
striking. In particular, at the level of the isolated cell the absence of zyxin prevented full
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Figure 7.1: Across multiple length scales, zyxin dynamically stabilizes the contractile apparatus. In
response to a transient stretch mimicking the eﬀect of a deep inspiration (DI), contracted airway smooth
muscle (ASM) ﬂuidizes rapidly and then resolidiﬁes slowly. Zyxin acts dynamically during the resolidiﬁ-
cation response to stabilize the contractile apparatus and its actin scaﬀolding at the levels of the stress
ﬁber, the isolated cell, and the integrated airway. At the molecular level (top panels), zyxin acts to stabi-
lize actin stress ﬁbers (SFs), thereby inhibiting cytoskeletal (CSK) remodeling. At the cellular level (middle
panels), net contractile force under isometric conditions and the rapid ﬂuidization in response to a DI are
independent of the cytoskeletal protein zyxin, whereas the slow resolidiﬁcation response is dependent
upon zyxin. At the integrated tissue level (bottom panels), zyxin similarly stabilizes the contractile appara-
tus in ASM, slowing airway dilation from DI. Across these multiple scales of length, zyxin acts dynamically
to promote cytoskeletal stabilization and resolidiﬁcation.103
Figure 7.2: Zyxin acts dynamically during the resolidiﬁcation response to stabilize the contractile
apparatus and its actin scaﬀolding. At the cellular level (left panel), under isometric conditions zyxin
is largely localized to cell adhesions. In response to an external mechanical stress, the cell ﬂuidizes and
zyxin localizes to sites of SF strain to facilitate their repair, stabilizing the contractile apparatus to again
support high traction force. At the integrated tissue level (right panel), in response to mechanical stress,
zyxin similarly stabilizes the contractile apparatus in ASM, slowing airway dilation from DI.
recovery of contractile forces in response to a DI (Figures 5.21, 5.22), whereas at the level
of the integrated airway the extent of reversal of airway narrowing by DIs did not depend
upon zyxin (Figure 6.4). Moreover, in the absence of zyxin the rate of airway dilation was
substantially faster (Figure 6.14). Slower recovery in the presence of zyxin is consistent
with the role of zyxin in stabilizing the contractile apparatus, however. Nonetheless, in
the integrated airway zyxin influenced the rate of recovery but did not influence the
extent of that recovery.
Taken together, these findings reveal important gaps of understanding. As regards the
prompt fluidization response, the question remains as to whether fluidization is driven
primarily by a passive breaking of acto-myosin bonds as well as other weak molecular
bonds [5, 25] or rather is driven primarily by active molecular disassembly through the
agency of actin-severing proteins. As regards the slow resolidification response, both the
striking inconsistencies across scales in the extent of recovery (Figures 5.21, 5.22, 6.10)
and in the rate of that recovery (Figures 5.21, 5.22, 6.14) I take to be important clues. It is
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not at all surprising that other cytoskeletal proteins besides zyxin might contribute to the
resolidification response, play a compensatory role, and thus account for these
inconsistencies. However, the specific molecular players, their roles, and their
interactions within the ASM cell are unknown and might include other LIM-domain
proteins, such as paxillin [115, 205], or others. Besides such specific compensatory
molecular events transpiring within the ASM cell, might other compensatory events
transpire without? For example, both prenatally and postnatally the developing airway is
subjected to an unending sequence of large tidal stretches [206]. In response, might the
airway of the zyxin =  mouse undergo compensatory developmental changes in muscle
mass, connective tissue structure, or tethering forces exerted between the airway and
surrounding lung parenchyma? Both within the ASM cell and without, our molecular
picture of airway dynamics remains at best fragmentary, and thus suggest that still other
unidentified events at a variety of levels might come into play. These possibilities
comprise interesting new questions.
I establish here a multi-scale approach that reveals a plausible phenotypic role for zyxin.
At the levels of the stress fiber, the isolated cell, and the integrated airway, these findings
support the idea that zyxin plays little or no role in the static isometric mechanical
properties of ASM but in response to physiological stretch zyxin acts dynamically to
stabilize the contractile apparatus and its scaﬀolding and promote resolidification. More
than just the motor of contraction, ASM is thus viewed in the broader context of a
self-healing active material wherein resolidification and its molecular determinants are
revealed as being important factors in the biology of bronchospasm.
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7.2 The Value of a Deeper Understanding of the Cytoskele-
tal Changes in Airway Smooth Muscle that Promote Bron-
chospasm
With these findings showing that zyxin regulates the dynamic contractility of ASM, our
understanding of the cytoskeletal changes that underlie bronchospasm is deepened. This
understanding could prove useful in the treatment of asthma. Existing asthma treatments
fall in three main categories: β2 adrenergic receptor (β2AR) agonists, corticosteroids and
leukotriene antagonists [207, 208]. In patients with infrequent and mild asthma
symptoms, short-acting β2AR agonists, which are highly eﬃcacious in reversing acute
bronchospasm, can be used alone to manage the disease [207, 208]. However, if patients
experience more severe and frequent symptoms, long-term medications must be used to
prevent symptoms [207, 208]. However, long-term treatments are not equally eﬃcacious
for all patients. Long-term use of β2AR agonists often leads to a decline in their
eﬀectiveness due to β2AR desensitization [209, 210]. In rare cases, this can even render
short-acting β2AR agonists less eﬀective [211]. In the case of corticosteroids, 5-10% of
patients are refractory to this treatment [47, 48]). Leukotriene antagonists, while
eﬀective for many patients and generally perceived to be safe, do not generally provide as
good control of asthma symptoms as corticosteroids, and are often a second choice
treatment [207, 208, 212, 213]. Long-term treatments to control bronchoconstriction
are especially important in light of recent research showing that bronchoconstriction in
the absence of airway inflammation can induce airway remodeling in asthmatics
[214, 215]. Accordingly, there exists a need for novel asthma treatments.
One potential target for the treatment of asthma is the ASM cell contractile apparatus.
Existing drugs that target the cell contractile apparatus (such as myosin inhibitors and
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actin disruptors) are too non-specific to safely or eﬀectively use in asthma treatment, and
so current asthma treatments do not yet directly target the cytoskeleton. However, if
zyxin, as indicated in this thesis, or other actin regulatory proteins promote the frozen
cytoskeletal state associated with bronchospasm, than they could possibly be safely
inhibited in order to promote a more fluid cytoskeleton and less contractile ASM.
7.3 Implications for FutureWork
Several directions for future work emerged from this thesis; I will discuss here some of
the most promising future directions. The first possible line of work indicated by this
thesis comprises an exploration of the role of zyxin in the mouse lung in vivo. This could
include both a study of the diﬀerences in lung function and airway responsiveness in the
live animal, as well as a comparative exploration of airway structure in wild type and
zyxin =  mice. Based on the intriguing findings in this thesis from the ex vivo airway in
PCLS, further study of airway resistance and airway hyperresponsiveness, as well as
responses to DI are indicated in vivo. The finding that zyxin slows rates of airway dilation
in the ex vivo airway could be followed up in the zyxin =  mouse in vivo, and possibly
elaborated upon through the use of an AHR mouse model. Further, as mentioned in the
previous chapter, it appears plausible that key variables in airway structure such as ASM
mass and basement membrane thickness could be diﬀerent between the wild type and
zyxin =  mouse, owing to zyxin’s indicated role in response to mechanical stretch and
the known mechanical strains imposed during lung development in vivo [206].
A second possible line of inquiry stemming from this work would be an examination of
other mechano-responsive actin regulatory proteins in the cell mechanical response to
stretch. Of these other potential regulators, paxillin stands outs as being of particular
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interest. Paxillin, like zyxin, is a LIM protein; it has four LIM domains near the
C-terminus of the protein [216]. These LIM domains target paxillin primarily to focal
adhesions [217], although recent work has indicated that, like zyxin, paxillin also
localizes to actin SFs [115]. Of particular interest, paxillin has been shown to localize to
sites of SF strain, where it stabilizes SFs independently of zyxin [115, 205]. It remains
unclear whether zyxin and paxillin-directed SF repair are parallel mechanisms, with each
serving as a backup for the other, or whether they are synergistic, working together via
diﬀerent mechanisms to promote SF stabilization. However, based on this evidence,
paxillin would be a particularly interesting candidate for further study in ASM and
bronchospasm. Other LIM proteins may also be good candidates for further study,
including the LIM kinases (LIMK1 and LIMK2), which are known to regulate actin
dynamics via the phosphorylation and inactivation of ADF/cofillin [114, 218]. Of
course, other actin regulatory proteins could be involved in the cell mechanical response
as well, including α-actinin and VASP, which are known to be involved in zyxin-mediated
stress fiber repair, or others [32].
Lastly, as discussed at length in Chapter 2 of this thesis, another possible direction for
future work would consist of a study of the molecular cause(s) of heterogeneity in cell
mechanics. To summarize here, it has been observed that cell mechanical measures,
including cellular contractility and stiﬀness, are log normally distributed [25, 83],
however, the causes of this apparent heterogeneity remain unclear. While some
hypotheses have been proposed, including focal adhesion size, cell spread area, and
aspect ratio [94–97], these are not able to fully account for the large variability observed
in mechanical measures of the cell. I propose that looking to the field of single cell
analysis could bring new insights to this problem. Single cell analysis has shown that gene
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expression in single cell is also highly heterogeneous [101–104] and often varies
according to a log normal distribution [103–107]. Accordingly, scientists in this field
have developed new techniques, including RNA FISH [122] and single-cell RNA-Seq
[117], to measure gene expression in single cells, which could be used in conjunction
with cell mechanical measures to study potential molecular determinants of mechanical
heterogeneity. This could inform our understanding of the molecular contribution
behind emergent cell mechanical phenotypes, and in turn identify new mechanisms
underlying cellular contractility.
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